Andrew Vickers
#59,425
Most Influential Person Now
Researcher
Andrew Vickers's AcademicInfluence.com Rankings
Andrew Vickerscomputer-science Degrees
Computer Science
#2346
World Rank
#2446
Historical Rank
#1044
USA Rank
Machine Learning
#159
World Rank
#160
Historical Rank
#47
USA Rank
Artificial Intelligence
#284
World Rank
#289
Historical Rank
#115
USA Rank
Database
#321
World Rank
#335
Historical Rank
#152
USA Rank
Download Badge
Computer Science
Andrew Vickers's Degrees
- PhD Computer Science Stanford University
- Masters Computer Science University of California, Berkeley
- Bachelors Computer Science University of California, Berkeley
Similar Degrees You Can Earn
Why Is Andrew Vickers Influential?
(Suggest an Edit or Addition)According to Wikipedia, Andrew Julian Vickers is a biostatistician and attending research methodologist at Memorial Sloan Kettering Cancer Center. Since 2013, he has also been professor of public health at Weill Cornell Medical College. He is the statistical editor for the peer-reviewed journal European Urology.
Andrew Vickers's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Assessing the Performance of Prediction Models: A Framework for Traditional and Novel Measures (2010) (3297)
- Decision Curve Analysis: A Novel Method for Evaluating Prediction Models (2006) (2839)
- Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration (2015) (2626)
- Analysing controlled trials with baseline and follow up measurements (2001) (1748)
- Chronic kidney disease after nephrectomy in patients with renal cortical tumours: a retrospective cohort study. (2006) (1453)
- A Contemporary Prostate Cancer Grading System: A Validated Alternative to the Gleason Score. (2016) (1075)
- Extensions to decision curve analysis, a novel method for evaluating diagnostic tests, prediction models and molecular markers (2008) (850)
- Prostate-specific antigen and prostate cancer: prediction, detection and monitoring (2008) (789)
- Acupuncture for chronic pain: individual patient data meta-analysis. (2012) (740)
- Increasing value and reducing waste: addressing inaccessible research (2014) (667)
- Do certain countries produce only positive results? A systematic review of controlled trials. (1998) (655)
- Net benefit approaches to the evaluation of prediction models, molecular markers, and diagnostic tests (2016) (540)
- Calibration: the Achilles heel of predictive analytics (2019) (494)
- The use of percentage change from baseline as an outcome in a controlled trial is statistically inefficient: a simulation study (2001) (456)
- Comparing Open Radical Cystectomy and Robot-assisted Laparoscopic Radical Cystectomy: A Randomized Clinical Trial. (2015) (450)
- Acupuncture for migraine prophylaxis. (2009) (447)
- Prostate cancer-specific mortality after radical prostatectomy for patients treated in the prostate-specific antigen era. (2009) (430)
- Acupuncture for Chronic Pain: Update of an Individual Patient Data Meta-Analysis. (2017) (408)
- Reporting and Interpreting Decision Curve Analysis: A Guide for Investigators. (2018) (401)
- Should supplemental antioxidant administration be avoided during chemotherapy and radiation therapy? (2008) (398)
- The surgical learning curve for prostate cancer control after radical prostatectomy. (2007) (380)
- Can Acupuncture have Specific Effects on Health? A Systematic Review of Acupuncture Antiemesis Trials (1996) (348)
- Empirical Study of Data Sharing by Authors Publishing in PLoS Journals (2009) (344)
- Impact of renal impairment on eligibility for adjuvant cisplatin‐based chemotherapy in patients with urothelial carcinoma of the bladder (2006) (341)
- Massage therapy for symptom control: outcome study at a major cancer center. (2004) (331)
- Parametric versus non-parametric statistics in the analysis of randomized trials with non-normally distributed data (2005) (316)
- Acupuncture for chronic headache in primary care: large, pragmatic, randomised trial (2004) (313)
- A simple, step-by-step guide to interpreting decision curve analysis (2019) (303)
- Metastasis after radical prostatectomy or external beam radiotherapy for patients with clinically localized prostate cancer: a comparison of clinical cohorts adjusted for case mix. (2010) (299)
- Pilot randomized controlled trial of individual meaning-centered psychotherapy for patients with advanced cancer. (2012) (298)
- Copy number alteration burden predicts prostate cancer relapse (2014) (295)
- Acupuncture-point stimulation for chemotherapy-induced nausea or vomiting. (2006) (294)
- Massage for promoting growth and development of preterm and/or low birth-weight infants. (2004) (282)
- Against quantiles: categorization of continuous variables in epidemiologic research, and its discontents (2012) (278)
- Age‐adjusted Charlson comorbidity score is associated with treatment decisions and clinical outcomes for patients undergoing radical cystectomy for bladder cancer (2008) (272)
- Strategy for detection of prostate cancer based on relation between prostate specific antigen at age 40-55 and long term risk of metastasis: case-control study (2013) (261)
- Systematic review of pretreatment prostate-specific antigen velocity and doubling time as predictors for prostate cancer. (2009) (253)
- The surgical learning curve for laparoscopic radical prostatectomy: a retrospective cohort study. (2009) (247)
- Users and practitioners of complementary medicine (1999) (246)
- Immediate effects of dry needling and acupuncture at distant points in chronic neck pain: results of a randomized, double-blind, sham-controlled crossover trial (2002) (245)
- Comparison of outcomes in elective partial vs radical nephrectomy for clear cell renal cell carcinoma of 4–7 cm (2006) (241)
- What is complementary medicine? (1999) (231)
- A panel of kallikrein markers can reduce unnecessary biopsy for prostate cancer: data from the European Randomized Study of Prostate Cancer Screening in Göteborg, Sweden (2008) (230)
- Prostate specific antigen concentration at age 60 and death or metastasis from prostate cancer: case-control study (2010) (228)
- Reducing unnecessary biopsy during prostate cancer screening using a four-kallikrein panel: an independent replication. (2010) (227)
- Prognostic and Prediction Tools in Bladder Cancer: A Comprehensive Review of the Literature. (2015) (224)
- Needle biopsies on autopsy prostates: sensitivity of cancer detection based on true prevalence. (2007) (223)
- Targeted Prostate Cancer Screening in BRCA1 and BRCA2 Mutation Carriers: Results from the Initial Screening Round of the IMPACT Study (2014) (222)
- Standardization of pelvic lymphadenectomy performed at radical cystectomy (2006) (215)
- NCCN Guidelines Insights: Prostate Cancer Early Detection, Version 2.2016. (2016) (215)
- Comparative risk‐adjusted mortality outcomes after primary surgery, radiotherapy, or androgen‐deprivation therapy for localized prostate cancer (2010) (212)
- Prostate Cancer Prevention Trial risk calculator 2.0 for the prediction of low- vs high-grade prostate cancer. (2014) (211)
- Acupuncture for Recurrent Headaches: A Systematic Review of Randomized Controlled Trials (1999) (211)
- Music therapy for mood disturbance during hospitalization for autologous stem cell transplantation (2003) (210)
- Accuracy of the EORTC risk tables and of the CUETO scoring model to predict outcomes in non-muscle-invasive urothelial carcinoma of the bladder (2013) (208)
- Long-term prediction of prostate cancer up to 25 years before diagnosis of prostate cancer using prostate kallikreins measured at age 44 to 50 years. (2007) (207)
- Prostate cancer early detection, Version 2.2016: Featured updates to the NCCN guidelines (2016) (206)
- Acupuncture for Chronic Pain: Individual Patient Data Meta-analysis (2012) (204)
- Prognostic significance of location of positive margins in radical prostatectomy specimens. (2007) (200)
- The association between total and positive lymph node counts, and disease progression in clinically localized prostate cancer. (2006) (199)
- ABC of Complementary Medicine (2000) (199)
- Acupuncture for tension-type headache. (2009) (197)
- Defining a standard set of patient-centered outcomes for men with localized prostate cancer. (2014) (195)
- Herbal medicine (1999) (189)
- Acupuncture for idiopathic headache. (2001) (186)
- Acupuncture for postchemotherapy fatigue: a phase II study. (2004) (186)
- Role of prostate specific antigen and immediate confirmatory biopsy in predicting progression during active surveillance for low risk prostate cancer. (2011) (184)
- Orally administered β-glucans enhance anti-tumor effects of monoclonal antibodies (2002) (184)
- Cost effectiveness analysis of a randomised trial of acupuncture for chronic headache in primary care (2004) (180)
- Nomogram Predicting Prostate Cancer-specific Mortality for Men with Biochemical Recurrence After Radical Prostatectomy. (2015) (178)
- Assessing the incremental value of diagnostic and prognostic markers: a review and illustration (2012) (177)
- Treatment paradigm shift may improve survival of patients with high risk superficial bladder cancer. (2007) (174)
- Tumor markers in prostate cancer I: Blood-based markers (2011) (174)
- Randomized, controlled trial of acupuncture for the treatment of hot flashes in breast cancer patients. (2007) (171)
- Comprehensive prospective comparative analysis of outcomes between open and laparoscopic radical prostatectomy conducted in 2003 to 2005. (2008) (169)
- Tumor copy number alteration burden is a pan-cancer prognostic factor associated with recurrence and death (2018) (169)
- Randomized Trial Comparing Open Radical Cystectomy and Robot-assisted Laparoscopic Radical Cystectomy: Oncologic Outcomes. (2018) (169)
- Botanical Medicines for the Treatment of Cancer: Rationale, Overview of Current Data, and Methodological Considerations for Phase I and II Trials (2002) (168)
- Critical review of prostate cancer predictive tools. (2009) (166)
- Predicting High-Grade Cancer at Ten-Core Prostate Biopsy Using Four Kallikrein Markers Measured in Blood in the ProtecT Study (2015) (164)
- One statistical test is sufficient for assessing new predictive markers (2011) (162)
- A phase I/II trial of a polysaccharide extract from Grifola frondosa (Maitake mushroom) in breast cancer patients: immunological effects (2009) (162)
- Comparison Between the Four-kallikrein Panel and Prostate Health Index for Predicting Prostate Cancer. (2015) (158)
- Acupuncture for pain and dysfunction after neck dissection: results of a randomized controlled trial. (2010) (156)
- Acupuncture-point stimulation for chemotherapy-induced nausea and vomiting. (2005) (156)
- Systematic reviews of complementary therapies - an annotated bibliography. Part 1: Acupuncture (2001) (155)
- Screening for prostate cancer with prostate-specific antigen testing: American Society of Clinical Oncology Provisional Clinical Opinion. (2012) (151)
- Contemporary use of partial nephrectomy at a tertiary care center in the United States. (2009) (148)
- Poorly differentiated prostate cancer treated with radical prostatectomy: long-term outcome and incidence of pathological downgrading. (2006) (148)
- How to randomize. (2006) (148)
- Prevalence of complementary therapy use by women with breast cancer. A population-based survey. (2000) (146)
- Calibration of Risk Prediction Models (2015) (146)
- Prediction of significant prostate cancer diagnosed 20 to 30 years later with a single measure of prostate‐specific antigen at or before age 50 (2011) (144)
- Whose data set is it anyway? Sharing raw data from randomized trials (2006) (142)
- Acupuncture for the prevention of tension-type headache. (2016) (139)
- Acupuncture for chronic pain. (2014) (138)
- Surgeon experience is strongly associated with biochemical recurrence after radical prostatectomy for all preoperative risk categories. (2008) (137)
- An empirical evaluation of guidelines on prostate-specific antigen velocity in prostate cancer detection. (2011) (136)
- Multi-institutional study of symptomatic deep venous thrombosis and pulmonary embolism in prostate cancer patients undergoing laparoscopic or robot-assisted laparoscopic radical prostatectomy. (2008) (135)
- Activator protein-1 transcription factors are associated with progression and recurrence of prostate cancer. (2008) (134)
- Predictive and prognostic models in radical prostatectomy candidates: a critical analysis of the literature. (2010) (132)
- Preparing raw clinical data for publication: guidance for journal editors, authors, and peer reviewers (2010) (132)
- Prostate cancer screening: facts, statistics, and interpretation in response to the US Preventive Services Task Force Review. (2012) (132)
- The Predictive Approaches to Treatment effect Heterogeneity (PATH) Statement (2019) (132)
- Improving the Specificity of Screening for Lethal Prostate Cancer Using Prostate-specific Antigen and a Panel of Kallikrein Markers: A Nested Case-Control Study. (2015) (131)
- Acupuncture of chronic headache disorders in primary care: randomised controlled trial and economic analysis. (2004) (130)
- Interim Results from the IMPACT Study: Evidence for Prostate-specific Antigen Screening in BRCA2 Mutation Carriers (2019) (129)
- Risk-based prostate cancer screening. (2012) (127)
- Using relative utility curves to evaluate risk prediction (2009) (125)
- Unconventional therapies for cancer and cancer-related symptoms. (2001) (124)
- ABC of complementary medicine. Acupuncture. (1999) (124)
- A systematic review of the volume-outcome relationship for radical prostatectomy. (2013) (122)
- Statistical consideration for clinical biomarker research in bladder cancer. (2010) (118)
- Decision Analysis for the Evaluation of Diagnostic Tests, Prediction Models, and Molecular Markers (2008) (118)
- High prevalence of complementary and alternative medicine use among cancer patients: implications for research and clinical care. (2005) (117)
- Massage therapies (1999) (117)
- Timing of curative treatment for prostate cancer: a systematic review. (2013) (116)
- The persistence of the effects of acupuncture after a course of treatment: a meta-analysis of patients with chronic pain (2017) (116)
- A Four-Kallikrein Panel Predicts Prostate Cancer in Men with Recent Screening: Data from the European Randomized Study of Screening for Prostate Cancer, Rotterdam (2010) (115)
- Individualized estimation of the benefit of radical prostatectomy from the Scandinavian Prostate Cancer Group randomized trial. (2012) (115)
- Characteristics of Acupuncture Treatment Associated with Outcome: An Individual Patient Meta-Analysis of 17,922 Patients with Chronic Pain in Randomised Controlled Trials (2013) (114)
- Cancer control and functional outcomes after radical prostatectomy as markers of surgical quality: analysis of heterogeneity between surgeons at a single cancer center. (2011) (113)
- FCGR2A polymorphism is correlated with clinical outcome after immunotherapy of neuroblastoma with anti-GD2 antibody and granulocyte macrophage colony-stimulating factor. (2006) (111)
- How Should we Research Unconventional Therapies? A Panel Report from the Conference on Complementary and Alternative Medicine Research Methodology, National Institutes of Health (1997) (111)
- Prostate-specific antigen at or before age 50 as a predictor of advanced prostate cancer diagnosed up to 25 years later: A case-control study (2008) (111)
- Why use placebos in clinical trials? A narrative review of the methodological literature. (2000) (111)
- Long-term prediction of prostate cancer: prostate-specific antigen (PSA) velocity is predictive but does not improve the predictive accuracy of a single PSA measurement 15 years or more before cancer diagnosis in a large, representative, unscreened population. (2008) (109)
- Importance of inhaler-device satisfaction in asthma treatment: Real-world observations of physician-observed compliance and clinical/patient-reported outcomes (2011) (108)
- Acupuncture for tension-type headache: a multicentre, sham-controlled, patient-and observer-blinded, randomised trial (2007) (108)
- Decision Curve Analysis: A Discussion (2008) (108)
- Systematic reviews of complementary therapies – an annotated bibliography. Part 3: Homeopathy (2001) (107)
- The learning curve for laparoscopic radical prostatectomy: an international multicenter study. (2010) (106)
- Complementary therapies and integrative oncology in lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). (2007) (104)
- A four-kallikrein panel for the prediction of repeat prostate biopsy: data from the European Randomized Study of Prostate Cancer Screening in Rotterdam, Netherlands (2010) (103)
- Importance of prostate volume in the European Randomised Study of Screening for Prostate Cancer (ERSPC) risk calculators: results from the prostate biopsy collaborative group (2011) (101)
- The learning curve for surgical margins after open radical prostatectomy: implications for margin status as an oncological end point. (2010) (101)
- How many repeated measures in repeated measures designs? Statistical issues for comparative trials (2003) (100)
- The status and future of acupuncture clinical research. (2008) (100)
- Influence of Control Group on Effect Size in Trials of Acupuncture for Chronic Pain: A Secondary Analysis of an Individual Patient Data Meta-Analysis (2014) (100)
- Effects of pathologic stage on the learning curve for radical prostatectomy: evidence that recurrence in organ-confined cancer is largely related to inadequate surgical technique. (2008) (99)
- Pretreatment prostate-specific antigen (PSA) velocity and doubling time are associated with outcome but neither improves prediction of outcome beyond pretreatment PSA alone in patients treated with radical prostatectomy. (2009) (98)
- COMPARISON OF AN ORDINAL AND A CONTINUOUS OUTCOME MEASURE OF MUSCLE SORENESS (1999) (98)
- Gender-specific differences in clinicopathologic outcomes following radical cystectomy: an international multi-institutional study of more than 8000 patients. (2014) (97)
- Influence of blood prostate specific antigen levels at age 60 on benefits and harms of prostate cancer screening: population based cohort study (2014) (97)
- Analysis of variance is easily misapplied in the analysis of randomized trials: a critique and discussion of alternative statistical approaches. (2005) (97)
- Temporary renal ischemia during nephron sparing surgery is associated with short-term but not long-term impairment in renal function. (2006) (95)
- Method for evaluating prediction models that apply the results of randomized trials to individual patients (2007) (94)
- The Relationship between Prostate-Specific Antigen and Prostate Cancer Risk: The Prostate Biopsy Collaborative Group (2010) (92)
- PSA Velocity and Doubling Time in Diagnosis and Prognosis of Prostate Cancer⋆ (2012) (91)
- Survival Outcomes of Men with Lymph Node-positive Prostate Cancer After Radical Prostatectomy: A Comparative Analysis of Different Postoperative Management Strategies. (2017) (90)
- Preparing raw clinical data for publication: guidance for journal editors, authors, and peer reviewers (2010) (90)
- Everything you always wanted to know about evaluating prediction models (but were too afraid to ask). (2010) (90)
- Extent of pelvic lymph node dissection and the impact of standard template dissection on nomogram prediction of lymph node involvement. (2011) (90)
- Underpowering in randomized trials reporting a sample size calculation. (2003) (90)
- A Panel of Kallikrein Marker Predicts Prostate Cancer in a Large, Population-Based Cohort Followed for 15 Years without Screening (2010) (89)
- Prediction models in cancer care (2011) (88)
- Association of Cysteine-Rich Secretory Protein 3 and β-Microseminoprotein with Outcome after Radical Prostatectomy (2007) (88)
- WITHDRAWN: Acupuncture-point stimulation for chemotherapy-induced nausea or vomiting. (2014) (88)
- Empirical estimates of prostate cancer overdiagnosis by age and prostate-specific antigen (2014) (86)
- Sixty Years of CA: A Cancer Journal for Clinicians (2010) (86)
- Prostate cancer early detection, version 1.2014. Featured updates to the NCCN Guidelines. (2014) (85)
- Predictive value of four kallikrein markers for pathologically insignificant compared with aggressive prostate cancer in radical prostatectomy specimens: results from the European Randomized Study of Screening for Prostate Cancer section Rotterdam. (2013) (83)
- Acupuncture for the prevention of episodic migraine. (2016) (83)
- Traditional statistical methods for evaluating prediction models are uninformative as to clinical value: towards a decision analytic framework. (2010) (83)
- Complementary and alternative therapies. (2003) (83)
- A Four-kallikrein Panel Predicts High-grade Cancer on Biopsy: Independent Validation in a Community Cohort. (2016) (83)
- Guidelines for reporting of statistics for clinical research in urology (2019) (82)
- Longitudinal risk of upper tract recurrence following radical cystectomy for urothelial cancer and the potential implications for long-term surveillance. (2008) (81)
- Preoperative predictive model of recovery of urinary continence after radical prostatectomy (2015) (81)
- Rituximab therapy of lymphoma is enhanced by orally administered (1-->3),(1-->4)-D-beta-glucan. (2005) (81)
- A Contemporary Prostate Biopsy Risk Calculator Based on Multiple Heterogeneous Cohorts. (2018) (80)
- Systematic reviews of complementary therapies – an annotated bibliography. Part 2: Herbal medicine (2001) (80)
- Complementary medicine (2000) (79)
- The clinically-integrated randomized trial: proposed novel method for conducting large trials at low cost (2009) (78)
- Integrative Oncology Practice Guidelines. (2007) (78)
- Guidelines for reporting of statistics in European Urology. (2015) (78)
- The added value of percentage of free to total prostate-specific antigen, PCA3, and a kallikrein panel to the ERSPC risk calculator for prostate cancer in prescreened men. (2014) (78)
- Complications after radical and partial nephrectomy as a function of age. (2010) (77)
- Acupuncture for dyspnea in advanced cancer: a randomized, placebo-controlled pilot trial [ISRCTN89462491] (2005) (77)
- Gleason 6 Prostate Cancer: Translating Biology into Population Health. (2015) (77)
- Time course of muscle soreness following different types of exercise (2001) (76)
- Evaluation of Markers and Risk Prediction Models (2013) (76)
- The National Cancer Institute's Conference on Acupuncture for Symptom Management in Oncology: State of the Science, Evidence, and Research Gaps. (2017) (76)
- Improved clinical outcome in recent years for men with metastatic nonseminomatous germ cell tumors. (2007) (75)
- Prostate cancer early detection version 1 (2014) (75)
- Does use of alternative medicine predict survival from cancer? (2003) (74)
- A regret theory approach to decision curve analysis: A novel method for eliciting decision makers' preferences and decision-making (2010) (74)
- Can we deliver randomized trials of focal therapy in prostate cancer? (2014) (74)
- A panel of kallikrein markers can predict outcome of prostate biopsy following clinical work-up: an independent validation study from the European Randomized Study of Prostate Cancer screening, France (2010) (74)
- Preoperative and postoperative nomograms incorporating surgeon experience for clinically localized prostate cancer (2009) (73)
- Prostate-specific antigen velocity for early detection of prostate cancer: result from a large, representative, population-based cohort. (2009) (73)
- The manipulative therapies: osteopathy and chiropractic (1999) (72)
- Impact of recent screening on predicting the outcome of prostate cancer biopsy in men with elevated prostate‐specific antigen (2010) (72)
- Preoperative and intraoperative risk factors for side-specific positive surgical margins in laparoscopic radical prostatectomy for prostate cancer. (2007) (72)
- Significance of intraoperative ureteral evaluation at radical cystectomy for urothelial cancer (2006) (70)
- Homeopathic Arnica 30x is ineffective for muscle soreness after long-distance running: a randomized, double-blind, placebo-controlled trial. (1998) (70)
- Setting the Bar in Phase II Trials: The Use of Historical Data for Determining “Go/No Go” Decision for Definitive Phase III Testing (2007) (70)
- Evaluating the PCPT risk calculator in ten international biopsy cohorts: results from the Prostate Biopsy Collaborative Group (2012) (69)
- Alternative medicine use worldwide (2001) (67)
- Reverse stage shift at a tertiary care center (2011) (67)
- Alternative Cancer Cures: “Unproven” or “Disproven”? (2004) (67)
- Predicting teratoma in the retroperitoneum in men undergoing post-chemotherapy retroperitoneal lymph node dissection. (2006) (67)
- Predicting Life Expectancy in Men Diagnosed with Prostate Cancer. (2015) (66)
- Variations among experienced surgeons in cancer control after open radical prostatectomy. (2010) (66)
- Blood Biomarker Levels to Aid Discovery of Cancer-Related Single-Nucleotide Polymorphisms: Kallikreins and Prostate Cancer (2010) (66)
- Baseline Prostate-Specific Antigen Levels in Midlife Predict Lethal Prostate Cancer. (2016) (66)
- Acupuncture in the Treatment of Upper-Limb Lymphedema (2013) (65)
- Evaluation of regional lymph node dissection in patients with upper urinary tract urothelial cancer (2007) (65)
- Modified technique for neurovascular bundle preservation during radical prostatectomy: association between technique and recovery of erectile function (2008) (65)
- Guidelines for Reporting of Statistics for Clinical Research in Urology. (2019) (65)
- The Predictive Approaches to Treatment effect Heterogeneity (PATH) Statement: Explanation and Elaboration (2019) (64)
- Impact of Acute Kidney Injury and Its Duration on Long-term Renal Function After Partial Nephrectomy. (2019) (64)
- Complementary medicine and the patient (1999) (64)
- A randomized comparison of homoeopathic and standard care for the treatment of glue ear in children. (1999) (63)
- Does a delay between diagnosis and radical prostatectomy increase the risk of disease recurrence? (2006) (63)
- Placebo Controls in Randomized Trials of Acupuncture (2002) (63)
- Overexpression of c-MYC promotes an undifferentiated phenotype in cultured astrocytes and allows elevated Ras and Akt signaling to induce gliomas from GFAP-expressing cells in mice. (2004) (63)
- Oncologic outcome after laparoscopic radical prostatectomy: 10 years of experience. (2009) (63)
- Evaluation of widely consumed botanicals as immunological adjuvants. (2008) (63)
- Individual patient data meta-analysis of acupuncture for chronic pain: protocol of the Acupuncture Trialists' Collaboration (2010) (62)
- Development and Evaluation of a New Frailty Index for Older Surgical Patients With Cancer (2019) (62)
- Low annual caseloads of United States surgeons conducting radical prostatectomy. (2009) (62)
- Milk thistle: effects on liver disease and cirrhosis and clinical adverse effects. (2000) (61)
- Susceptibility Loci Associated with Prostate Cancer Progression and Mortality (2010) (61)
- Are We Improving Erectile Function Recovery After Radical Prostatectomy? Analysis of Patients Treated over the Last Decade. (2019) (60)
- Evaluation of multiple risk-associated single nucleotide polymorphisms versus prostate-specific antigen at baseline to predict prostate cancer in unscreened men. (2012) (60)
- The surgical learning curve for artificial urinary sphincter procedures compared to typical surgeon experience. (2011) (60)
- Acupuncture for the treatment of post-chemotherapy chronic fatigue: a randomized, blinded, sham-controlled trial (2013) (59)
- Prediction models: revolutionary in principle, but do they do more good than harm? (2011) (59)
- Complementary medicine and the Cochrane Collaboration. (1998) (58)
- Unexpected Long-term Improvements in Urinary and Erectile Function in a Large Cohort of Men with Self-reported Outcomes Following Radical Prostatectomy. (2015) (58)
- Garlic: effects on cardiovascular risks and disease, protective effects against cancer, and clinical adverse effects. (2000) (58)
- Association of cancer with moderately impaired renal function at baseline in a large, representative, population‐based cohort followed for up to 30 years (2013) (57)
- The Memorial Sloan Kettering Cancer Center Recommendations for Prostate Cancer Screening. (2016) (56)
- Assessing the clinical benefit of nuclear matrix protein 22 in the surveillance of patients with nonmuscle‐invasive bladder cancer and negative cytology (2011) (56)
- Validation study of a web-based assessment of functional recovery after radical prostatectomy (2010) (56)
- Comparison of free and total forms of serum human kallikrein 2 and prostate-specific antigen for prediction of locally advanced and recurrent prostate cancer. (2007) (56)
- Cost-effectiveness of adjunct non-pharmacological interventions for osteoarthritis of the knee (2017) (56)
- The Brier score does not evaluate the clinical utility of diagnostic tests or prediction models (2017) (56)
- Complementary medicine and the doctor (1999) (56)
- A phase IIA trial of acupuncture to reduce chemotherapy-induced peripheral neuropathy severity during neoadjuvant or adjuvant weekly paclitaxel chemotherapy in breast cancer patients. (2018) (55)
- Safety and pharmacokinetic trial of docetaxel plus an Astragalus-based herbal formula for non-small cell lung cancer patients (2009) (55)
- Message to complementary and alternative medicine: evidence is a better friend than power (2001) (54)
- Risk-adjusted analysis of positive surgical margins following laparoscopic and retropubic radical prostatectomy. (2007) (54)
- Risk assessment for biochemical recurrence prior to radical prostatectomy: Significant enhancement contributed by human glandular kallikrein 2 (hK2) and free prostate specific antigen (PSA) in men with moderate PSA‐elevation in serum (2006) (54)
- Statistical Reanalysis of Four Recent Randomized Trials of Acupuncture for Pain Using Analysis of Covariance (2004) (53)
- Clinical trials of homeopathy and placebo: analysis of a scientific debate. (2000) (53)
- Cancer‐specific survival and predictors of prostate‐specific antigen recurrence and survival in patients with seminal vesicle invasion after radical prostatectomy (2006) (53)
- Randomized controlled trial of a special acupuncture technique for pain after thoracotomy. (2008) (53)
- The predictive value of prostate cancer biomarkers depends on age and time to diagnosis: Towards a biologically‐based screening strategy (2007) (52)
- Screening for prostate cancer: early detection or overdetection? (2012) (52)
- Multimorbidity and Evidence Generation (2014) (52)
- Role of Changes in Magnetic Resonance Imaging or Clinical Stage in Evaluation of Disease Progression for Men with Prostate Cancer on Active Surveillance. (2019) (52)
- The Impact of Experience on the Risk of Surgical Margins and Biochemical Recurrence after Robot-Assisted Radical Prostatectomy: A Learning Curve Study. (2019) (52)
- An empirical study of race times in recreational endurance runners (2016) (51)
- Limited versus Extended Pelvic Lymph Node Dissection for Prostate Cancer: A Randomized Clinical Trial. (2021) (51)
- Homoeopathic Oscillococcinum for preventing and treating influenza and influenza-like syndromes. (2006) (51)
- Adverse Pathologic Features at Radical Prostatectomy: Effect of Preoperative Risk on Oncologic Outcomes. (2016) (50)
- ABC of complementary medicine. Homoeopathy. (1999) (50)
- Cytoreductive Nephrectomy and Nephrectomy/Complete Metastasectomy for Metastatic Renal Cancer (2007) (50)
- Prostate Cancer Early Detection, Version 2.2015 (2015) (50)
- Does the Net Reclassification Improvement Help Us Evaluate Models and Markers? (2014) (50)
- Hypnosis and relaxation therapies (1999) (50)
- Risk of Cancer-specific Mortality following Recurrence After Radical Nephroureterectomy (2012) (50)
- Longitudinal assessment of quality of life after surgery, conformal brachytherapy, and intensity-modulated radiation therapy for prostate cancer. (2016) (49)
- Clinical characteristics of bladder cancer in patients previously treated with radiation for prostate cancer (2006) (49)
- A commentary on PSA velocity and doubling time for clinical decisions in prostate cancer. (2014) (49)
- Free PSA isoforms and intact and cleaved forms of urokinase plasminogen activator receptor in serum improve selection of patients for prostate cancer biopsy (2007) (49)
- Anatomy of accessory pudendal arteries in laparoscopic radical prostatectomy. (2005) (48)
- Effect of repeated prostate biopsies on erectile function in men on active surveillance for prostate cancer. (2014) (47)
- Impact of a multidisciplinary continuous quality improvement program on the positive surgical margin rate after laparoscopic radical prostatectomy. (2006) (47)
- Electronic Rapid Fitness Assessment: A Novel Tool for Preoperative Evaluation of the Geriatric Oncology Patient. (2017) (47)
- A single arm phase II study of a Far-Eastern traditional herbal formulation (sho-sai-ko-to or xiao-chai-hu-tang) in chronic hepatitis C patients. (2011) (47)
- What is a p-value anyway? 34 Stories to Help You Actually Understand Statistics (2009) (47)
- Massage and Aromatherapy: A Guide for Health Professionals (1996) (46)
- Pelvic lymph node dissection for patients with elevated risk of lymph node invasion during radical prostatectomy: comparison of open, laparoscopic and robot-assisted procedures. (2012) (46)
- Association of Geriatric Comanagement and 90-Day Postoperative Mortality Among Patients Aged 75 Years and Older With Cancer (2020) (46)
- Prostate Cancer Mortality in Areas With High and Low Prostate Cancer Incidence (2014) (45)
- Screening for Prostate Cancer Starting at Age 50-54 Years. A Population-based Cohort Study. (2017) (45)
- Independent Replication of Pre-Clinical Research in Homoeopathy: A Systematic Review (1999) (45)
- Long‐Term Cancer Specific Anxiety in Men Undergoing Active Surveillance of Prostate Cancer: Findings from a Large Prospective Cohort (2018) (45)
- Prospective randomized evaluation of risk-adapted prostate-specific antigen screening in young men: the PROBASE trial. (2013) (44)
- Clinical trials in crisis: Four simple methodologic fixes (2014) (44)
- Decision curve analysis to evaluate the clinical benefit of prediction models. (2021) (44)
- Statistical methods to correct for verification bias in diagnostic studies are inadequate when there are few false negatives: a simulation study (2008) (44)
- Levels of beta-microseminoprotein in blood and risk of prostate cancer in multiple populations. (2013) (44)
- Sialyltransferase STX (ST8SiaII): A novel molecular marker of metastatic neuroblastoma (2006) (44)
- Evaluation of Prediction Models for Decision-Making: Beyond Calibration and Discrimination (2013) (43)
- Statistics Notes: Missing outcomes in randomised trials (2013) (43)
- Homoeopathic Oscillococcinum for preventing and treating influenza and influenza-like syndromes. (2000) (43)
- A safety and efficacy pilot study of acupuncture for the treatment of chronic lymphoedema (2011) (43)
- Erratum: Comparative risk‐adjusted mortality outcomes after primary surgery, radiotherapy, or androgen‐deprivation therapy for localized prostate cancer (2011) (42)
- Long-Term Outcomes of Active Surveillance for Prostate Cancer - The Memorial Sloan Kettering Cancer Center Experience. (2019) (41)
- Routine Use of Magnetic Resonance Imaging for Early Detection of Prostate Cancer Is Not Justified by the Clinical Trial Evidence. (2020) (41)
- Urinary cell mRNA profiles and differential diagnosis of acute kidney graft dysfunction. (2014) (41)
- Use of Digital Rectal Examination as an Adjunct to Prostate Specific Antigen in the Detection of Clinically Significant Prostate Cancer (2017) (41)
- Homoeopathy for delayed onset muscle soreness: a randomised double blind placebo controlled trial. (1997) (40)
- Bibliometric analysis of randomized trials in complementary medicine (1998) (40)
- A Simple Schema for Informed Decision Making About Prostate Cancer Screening (2014) (40)
- Genetic Polymorphisms of CFH and ARMS2 Do Not Predict Response to Antioxidants and Zinc in Patients with Age-Related Macular Degeneration: Independent Statistical Evaluations of Data from the Age-Related Eye Disease Study. (2017) (39)
- Terminology and Definitions (2003) (39)
- Relative value of race, family history and prostate specific antigen as indications for early initiation of prostate cancer screening. (2014) (39)
- Systematic review of statistical methods used in molecular marker studies in cancer (2008) (38)
- Preexisting Cardiovascular Risk and Subsequent Heart Failure Among Non-Hodgkin Lymphoma Survivors. (2017) (38)
- Combining smoking information and molecular markers improves prognostication in patients with urothelial carcinoma of the bladder. (2014) (38)
- Prostate Specific Antigen and Prostate Cancer in Chinese Men Undergoing Initial Prostate Biopsies Compared with Western Cohorts (2016) (38)
- Definition of biochemical recurrence after radical prostatectomy does not substantially impact prognostic factor estimates. (2010) (38)
- Treating Metastatic Disease: Which Survival Model Is Best Suited for the Clinic? (2013) (37)
- Who should be included in a clinical trial of screening for bladder cancer? (2013) (37)
- INCORPORATING DATA FROM DISSERTATIONS IN SYSTEMATIC REVIEWS (2000) (37)
- Acupuncture for chronic pain and depression in primary care: a programme of research (2017) (37)
- Double‐Blind, Placebo‐Controlled, Randomized Trial of Granulocyte‐Colony Stimulating Factor During Postoperative Radiotherapy for Squamous Head and Neck Cancer (2006) (36)
- Baseline Prostate-specific Antigen Level in Midlife and Aggressive Prostate Cancer in Black Men. (2019) (36)
- Screening for Prostate Cancer. (2020) (36)
- Making raw data more widely available (2011) (35)
- Acupuncture for migraine and headache in primary care: a protocol for a pragmatic, randomized trial. (1999) (35)
- Evaluating the Prostate Cancer Prevention Trial High Grade prostate cancer risk calculator in 10 international biopsy cohorts: results from the prostate biopsy collaborative group (2014) (35)
- Decisional Conflict, Regret, and the Burden of Rational Decision Making (2017) (35)
- Evaluation of specific and non-specific effects in homeopathy: Feasibility study for a randomised trial (2000) (34)
- A Phase II, Randomized, Controlled Trial of Acupuncture for Reduction of Postcolectomy Ileus (2013) (34)
- Effects of pathological upstaging or upgrading on metastasis and cancer‐specific mortality in men with clinical low‐risk prostate cancer (2018) (34)
- Fellowship Training as a Modifier of the Surgical Learning Curve (2010) (34)
- Empirical Estimates of the Lead Time Distribution for Prostate Cancer Based on Two Independent Representative Cohorts of Men Not Subject to Prostate-Specific Antigen Screening (2010) (33)
- Positive surgical margins and accessory pudendal artery preservation during laparoscopic radical prostatectomy. (2005) (33)
- Selecting patients for randomized trials: a systematic approach based on risk group (2006) (33)
- San Code of Research Ethics (2017) (33)
- Electronic patient self-assessment and management (SAM): a novel framework for cancer survivorship (2010) (32)
- Improving patient prostate cancer risk assessment: Moving from static, globally-applied to dynamic, practice-specific risk calculators (2015) (32)
- Twenty-year Risk of Prostate Cancer Death by Midlife Prostate-specific Antigen and a Panel of Four Kallikrein Markers in a Large Population-based Cohort of Healthy Men. (2018) (31)
- Clinical Usefulness of Total Length of Gleason Pattern 4 on Biopsy in Men with Grade Group 2 Prostate Cancer (2019) (31)
- NCCN Clinical Practice Guidelines Prostate Cancer Early Detection, Version 2.2015. (2015) (31)
- Which botanicals or other unconventional anticancer agents should we take to clinical trial? (2007) (30)
- Radical prostatectomy shortly after prostate biopsy does not affect operative difficulty or efficacy. (2007) (30)
- A case‐mix‐adjusted comparison of early oncological outcomes of open and robotic prostatectomy performed by experienced high volume surgeons (2013) (30)
- Impact of stage migration and practice changes on high‐risk prostate cancer: results from patients treated with radical prostatectomy over the last two decades (2016) (30)
- How do you know if you are any good? A surgeon performance feedback system for the outcomes of radical prostatectomy. (2012) (29)
- Natural history of positive urinary cytology after radical cystectomy. (2006) (29)
- A systematic literature review of life expectancy prediction tools for patients with localized prostate cancer. (2015) (29)
- Hypnosis and relaxation therapies. (2001) (29)
- Acupuncture is a feasible treatment for post-thoracotomy pain: results of a prospective pilot trial (2006) (29)
- A Systematic Approach to Discussing Active Surveillance with Patients with Low-risk Prostate Cancer. (2017) (29)
- Risk of Metastasis in Men with Grade Group 2 Prostate Cancer Managed with Active Surveillance at a Tertiary Cancer Center. (2020) (28)
- Lessons of War: Turning Data Into Decisions☆☆☆ (2015) (28)
- Prostate specific antigen velocity does not aid prostate cancer detection in men with prior negative biopsy. (2010) (28)
- Magnitude‐based Inference is not Bayesian and is not a valid method of inference (2019) (28)
- Beyond prostate-specific antigen: utilizing novel strategies to screen men for prostate cancer (2016) (28)
- Can Confirmatory Biopsy be Omitted in Patients with Prostate Cancer Favorable Diagnostic Features on Active Surveillance? (2016) (28)
- Novel approaches to improve prostate cancer diagnosis and management in early‐stage disease (2012) (28)
- Temporal Trend in Incidental Prostate Cancer Detection at Surgery for Benign Prostatic Hyperplasia. (2018) (27)
- How many lymphadenectomies does it take to cure one patient? (2008) (27)
- Methodological issues in complementary and alternative medicine research: a personal reflection on 10 years of debate in the United Kingdom. (1996) (27)
- Cutpoints in clinical chemistry: time for fundamental reassessment. (2009) (27)
- Anti-GD2 antibody 3F8 and barley-derived (1 → 3),(1 → 4)-β-D-glucan (2013) (27)
- Systematic review of the use of “magnitude-based inference” in sports science and medicine (2020) (27)
- Is it necessary to remove the seminal vesicles completely at radical prostatectomy? decision curve analysis of European Society of Urologic Oncology criteria. (2009) (26)
- Unconventional anticancer agents: a systematic review of clinical trials. (2006) (26)
- Challenges in Adopting Level 1 Evidence for Multiparametric Magnetic Resonance Imaging as a Biomarker for Prostate Cancer Screening. (2018) (25)
- Why aromatherapy works (even if it doesn't) and why we need less research. (2000) (25)
- Inhibition of Circulating Dipeptidyl Peptidase 4 Activity in Patients with Metastatic Prostate Cancer* (2014) (25)
- Acupuncture for Tension-Type Headache: a Multicentre, Sham-Controlled, Patient and Observer-Blinded, Randomised Trial (2008) (25)
- Cyclin D1, a novel molecular marker of minimal residual disease, in metastatic neuroblastoma. (2007) (25)
- Perioperative clinical thromboembolic events after radical or partial nephrectomy. (2006) (25)
- Clinical benefits of a multivariate prediction model for bladder cancer (2009) (25)
- Use of complementary therapies (1994) (24)
- Acupuncture for breast cancer-related lymphedema: a randomized controlled trial (2018) (24)
- Clinical and biomarker endpoint analysis in neoadjuvant endocrine therapy trials (2005) (24)
- Evaluation of prediagnostic prostate‐specific antigen dynamics as predictors of death from prostate cancer in patients treated conservatively (2011) (24)
- Net reclassification improvement and decision theory (2009) (24)
- Massage and Aromatherapy (1996) (23)
- Number-needed-to-treat and placebo-controlled trials (1998) (23)
- Prostate Cancer Screening: Time to Question How to Optimize the Ratio of Benefits and Harms (2017) (23)
- Predictors of survival in patients with disease recurrence after radical nephroureterectomy (2014) (23)
- Cancer control and functional outcomes after radical prostatectomy as markers of surgical quality: analysis of heterogeneity between surgeons at a single cancer center (2011) (23)
- Effects of surgeon variability on oncologic and functional outcomes in a population-based setting (2014) (23)
- Can homeopathically prepared mercury cause symptoms in healthy volunteers? A randomized, double-blind placebo-controlled trial. (2001) (23)
- Cancer-associated changes in the expression of TMPRSS2-ERG, PCA3, and SPINK1 in histologically benign tissue from cancerous vs noncancerous prostatectomy specimens. (2014) (23)
- Call to increase statistical collaboration in sports science, sport and exercise medicine and sports physiotherapy (2020) (22)
- Effects of Magnetic Resonance Imaging Targeting on Overdiagnosis and Overtreatment of Prostate Cancer. (2021) (22)
- Evaluation of molecular forms of prostate‐specific antigen and human kallikrein 2 in predicting biochemical failure after radical prostatectomy (2009) (22)
- Successful external validation of a model to predict other cause mortality in localized prostate cancer (2016) (22)
- It ain't what you do, it's the way you do it: five golden rules for transforming prostate-specific antigen screening. (2014) (22)
- Estimating the harms and benefits of prostate cancer screening as used in common practice versus recommended good practice: A microsimulation screening analysis (2016) (22)
- Statistical considerations for use of composite health-related quality-of-life scores in randomized trials (2004) (22)
- Are we ready to predict late effects? A systematic review of clinically useful prediction models. (2015) (22)
- Introduction to complementary medicine (1996) (21)
- Finasteride to prevent prostate cancer: should all men or only a high-risk subgroup be treated? (2010) (21)
- Detection of High Grade Prostate Cancer among PLCO Participants Using a Prespecified 4‐Kallikrein Marker Panel (2017) (21)
- The patient-physician partnership in asthma: Real-world observations associated with clinical and patient-reported outcomes (2010) (21)
- Massage for promoting growth and development of preterm and/or low birth-weight infants. (2004) (21)
- Comparison of models to predict clinical failure after radical prostatectomy (2009) (21)
- Properties of the 4‐Kallikrein Panel Outside the Diagnostic Gray Zone: Meta‐Analysis of Patients with Positive Digital Rectal Examination or Prostate Specific Antigen 10 ng/ml and Above (2017) (20)
- Predicting prostate cancer many years before diagnosis: how and why? (2012) (20)
- Against Diagnosis (2008) (20)
- Prostate-specific antigen test for prostate cancer screening: American Society of Clinical Oncology provisional clinical opinion. (2012) (20)
- Clinical Usefulness of Prostate and Tumor Volume Related Parameters following Radical Prostatectomy for Localized Prostate Cancer (2019) (19)
- Sharing raw data from clinical trials: what progress since we first asked “Whose data set is it anyway?” (2016) (19)
- Homoeopathic Arnica and Rhus toxicodendron for delayed onset muscle soreness (1997) (19)
- Long‐term oncological outcomes of a phase II trial of neoadjuvant chemohormonal therapy followed by radical prostatectomy for patients with clinically localised, high‐risk prostate cancer (2015) (19)
- Comparison of three different tools for prediction of seminal vesicle invasion at radical prostatectomy. (2012) (18)
- Ambulatory cancer care electronic symptom self-reporting (ACCESS) for surgical patients: a randomised controlled trial protocol (2019) (18)
- WITHDRAWN: Homoeopathic Oscillococcinum for preventing and treating influenza and influenza-like syndromes. (2009) (18)
- Prediction models in urology: are they any good, and how would we know anyway? (2010) (18)
- The Effect of Patient Characteristics on Acupuncture Treatment Outcomes: An Individual Patient Data Meta-Analysis of 20,827 Chronic Pain Patients in Randomized Controlled Trials (2019) (18)
- Outcomes and Safety Among Patients With Obstructive Sleep Apnea Undergoing Cancer Surgery Procedures in a Freestanding Ambulatory Surgical Facility. (2019) (18)
- Incorporating predictions of individual patient risk in clinical trials. (2004) (18)
- Soy: An Anticancer Agent In Wide Use Despite Some Troubling Data (2003) (18)
- Critical appraisal: How to read a clinical research paper (1995) (17)
- Prostate-specific antigen velocity in a prospective prostate cancer screening study of men with genetic predisposition (2018) (17)
- The Four-Kallikrein Panel Is Effective in Identifying Aggressive Prostate Cancer in a Multiethnic Population (2020) (17)
- Do the data support the comorbidity hypothesis for the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial results? (2011) (17)
- Prostate cancer: Estimating the benefits of PSA screening (2009) (17)
- Susceptibility loci associated with prostate cancer progression and mortality. (2010) (17)
- Association Between Lead Time and Prostate Cancer Grade: Evidence of Grade Progression from Long-term Follow-up of Large Population-based Cohorts Not Subject to Prostate-specific Antigen Screening. (2017) (17)
- Advice Given by Health Food Shops: Is It Clinically Safe? (1998) (17)
- Low-Grade Prostate Cancer: Time to Stop Calling It Cancer. (2022) (17)
- A Systematic Review of the Literature Demonstrates Some Errors in the Use of Decision Curve Analysis but Generally Correct Interpretation of Findings (2019) (16)
- Examining complementary medicine : the sceptical holist (1998) (16)
- Comparison of observed biochemical recurrence-free survival in patients with low PSA values undergoing radical prostatectomy and predictions of preoperative nomogram. (2008) (16)
- Counseling the post-radical prostatectomy patients about functional recovery: high predictiveness of current status. (2014) (16)
- Health-related Quality of Life for Patients Undergoing Radical Cystectomy: Results of a Large Prospective Cohort. (2021) (16)
- Individual Patient Data Meta-analysis (2012) (15)
- Primer: using decision analysis to improve clinical decision making in urology (2006) (15)
- Can homeopaths detect homeopathic medicines? A pilot study for a randomised, double-blind, placebo controlled investigation of the proving hypothesis (2001) (15)
- Clinical Findings and Treatment Outcomes in Patients with Extraprostatic Extension Identified on Prostate Biopsy. (2016) (15)
- Do we want more cancer patients on clinical trials If so, what are the barriers to greater accrual (2008) (15)
- Basic and Clinical Aspects of Vertigo and Dizziness (2009) (15)
- The Lake Wobegon Effect: Why Most Patients Are at Below-Average Risk (2015) (15)
- The Role of Magnetic Resonance Imaging and Positron Emission Tomography/Computed Tomography in the Primary Staging of Newly Diagnosed Prostate Cancer: A Systematic Review of the Literature. (2020) (15)
- Standardizing Opioid Prescriptions to Patients After Ambulatory Oncologic Surgery Reduces Overprescription. (2020) (15)
- Just-in-time consent: The ethical case for an alternative to traditional informed consent in randomized trials comparing an experimental intervention with usual care (2018) (14)
- Prespecified Four Kallikrein Marker Model (4Kscore) at Age 50 or 60 for Early Detection of Lethal Prostate Cancer in a Large Population-Based Cohort of Asymptomatic Men Followed for 20 Years. (2020) (14)
- The Prostate Cancer Prevention Trial risk calculator and the relationship between prostate‐specific antigen and biopsy outcome (2013) (14)
- Yes, but how do we know it's true? Knowledge claims in massage and aromatherapy. (1997) (14)
- Interpreting Patient Reported Urinary and Sexual Function Outcomes across Multiple Validated Instruments (2017) (14)
- The ethics of ‘Trials within Cohorts’ (TwiCs): 2nd international symposium (2017) (14)
- The ethics of ‘Trials within Cohorts’ (TwiCs): 2nd international symposium (2017) (14)
- Who and when should we screen for prostate cancer? Interviews with key opinion leaders (2015) (14)
- Nonlinear modeling was applied thoughtfully for risk prediction: the Prostate Biopsy Collaborative Group. (2015) (14)
- Evidence-based medicine and complementary medicine (1999) (14)
- Redesigning Prostate Cancer Screening Strategies to Reduce Overdiagnosis. (2019) (13)
- Placebo in acupuncture trials (2004) (13)
- CLINICAL BENEFITS OF A MULTIVARIABLE PREDICTION MODEL FOR BLADDER CANCER: A DECISION ANALYTIC APPROACH (2008) (13)
- Markers for the early detection of prostate cancer: some principles for statistical reporting and interpretation. (2014) (13)
- Impact of intraoperative remifentanil on postoperative pain and opioid use in thyroid surgery (2019) (13)
- Guidelines for Reporting of Statistics for Clinical Research in Urology (2019) (13)
- Spotlight on prostate cancer: the latest evidence and current controversies (2015) (13)
- Unconventional approaches to nutritional medicine (1999) (13)
- Prevalence of Complementary and Alternative Medicine Use in Cancer Patients (2001) (13)
- Systematic Reviews of Herbal Medicines – an Annotated Bibliography (2003) (13)
- Analysis of the evidence profile of the effectiveness of complementary therapies in asthma: A qualitative survey and systematic review (1997) (13)
- OA03.01. Acupuncture for chronic pain: an individual patient data meta-analysis of randomized trials (2012) (13)
- PROSTATE CANCER-SPECIFIC MORTALITY AFTER RADICAL PROSTATECTOMY FOR PATIENTS TREATED IN THE PROSTATE- SPECIFIC ANTIGEN ERA (2008) (13)
- Association Between Electronic Patient Symptom Reporting With Alerts and Potentially Avoidable Urgent Care Visits After Ambulatory Cancer Surgery. (2021) (13)
- How do you tell whether a change in surgical technique leads to a change in outcome? (2010) (12)
- Methods for network meta-analysis of continuous outcomes using individual patient data: a case study in acupuncture for chronic pain (2016) (12)
- A simple decision analytic solution to the comparison of two binary diagnostic tests (2013) (12)
- Anthropometric Measures at Multiple Times Throughout Life and Prostate Cancer Diagnosis, Metastasis, and Death. (2015) (12)
- Massage therapy for preterm and/or low birth‐weight infants (1999) (12)
- Relative Contribution of Sampling and Grading to the Quality of Prostate Biopsy: Results from a Single High-volume Institution. (2020) (12)
- The Next Generation of Clinical Decision Making Tools: Development of a Real-Time Prediction Tool for Outcome of Prostate Biopsy in Response to a Continuously Evolving Prostate Cancer Landscape. (2015) (12)
- Lifetime Benefits and Harms of Prostate-Specific Antigen–Based Risk-Stratified Screening for Prostate Cancer (2020) (12)
- Acupuncture (1999) (12)
- Point/Counterpoint: early detection of prostate cancer: do the benefits outweigh the consequences? (2014) (12)
- What are the implications of the surgical learning curve? (2014) (11)
- Introducing BREAST-Q Computerized Adaptive Testing: Short and Individualized Patient-Reported Outcome Assessment following Reconstructive Breast Surgery (2019) (11)
- Incorporating Multiple Perspectives Into the Development of an Electronic Survivorship Platform for Head and Neck Cancer. (2018) (11)
- How to design a phase I trial of an anticancer botanical. (2006) (11)
- Value of a Statistical Model Based on Four Kallikrein Markers in Blood, Commercially Available as 4Kscore, in All Reasonable Prostate Biopsy Subgroups. (2018) (11)
- MRI-guided focused ultrasound focal therapy for patients with intermediate-risk prostate cancer: a phase 2b, multicentre study. (2022) (11)
- Development and Validation of Crosswalks for Patient-reported Sexual and Urinary Outcomes Between Commonly Used Instruments. (2019) (11)
- Minimally Invasive Partial Nephrectomy Versus Laparoscopic Cryoablation for Patients Newly Diagnosed with a Single Small Renal Mass. (2015) (10)
- Implementation of Dynamically Updated Prediction Models at the Point of Care at a Major Cancer Center: Making Nomograms More Like Netflix. (2017) (10)
- Why can't nomograms be more like Netflix? (2010) (10)
- Rapid elimination kinetics of free PSA or human kallikrein-related peptidase 2 after initiation of gonadotropin-releasing hormone-antagonist treatment of prostate cancer: potential for rapid monitoring of treatment responses (2012) (10)
- Incidence and Effect of Thromboembolic Events in Radical Cystectomy Patients Undergoing Preoperative Chemotherapy for Muscle‐invasive Bladder Cancer (2017) (10)
- Evidence-based medicine and complementary medicine (1998) (10)
- We need a better marker for prostate cancer. How about renaming PSA? (2012) (10)
- Regulating complementary medicine (1996) (10)
- Complementary therapies on the NHS: the NAHAT survey (1994) (10)
- Risk Based Surveillance after Surgical Treatment of Renal Cell Carcinoma (2018) (10)
- A Four-kallikrein Panel and β-Microseminoprotein in Predicting High-grade Prostate Cancer on Biopsy: An Independent Replication from the Finnish Section of the European Randomized Study of Screening for Prostate Cancer. (2017) (10)
- Statistical Code for Clinical Research Papers in a High-Impact Specialist Medical Journal (2018) (10)
- Frailty based on the memorial Sloan Kettering Frailty Index is associated with surgical decision making, clinical trial participation, and overall survival among older women with ovarian cancer. (2021) (10)
- Great meaningless questions in urology: which is better, open, laparoscopic, or robotic radical prostatectomy? (2011) (10)
- Improved Recovery of Erectile Function in Younger Men after Radical Prostatectomy: Does it Justify Immediate Surgery in Low-risk Patients? (2018) (10)
- Intraoperative Ketorolac is Associated with Risk of Reoperation After Mastectomy: A Single-Center Examination (2021) (10)
- Active surveillance for prostate cancer (2021) (9)
- Point-Counterpoint: Using Clinical Trials for the Evaluation of Integrative Cancer Therapies (2004) (9)
- Lifetime benefits and harms of PSA-based risk screening for prostate cancer. (2020) (9)
- Updating the International Index of Erectile Function: Evaluation of a Large Clinical Data Set. (2019) (9)
- Can one blood draw replace transrectal ultrasonography‐estimated prostate volume to predict prostate cancer risk? (2013) (9)
- Developing an effective strategy to improve the detection of significant prostate cancer by combining the 4Kscore and multiparametric MRI. (2019) (9)
- Statistical Analysis and Reporting Guidelines for CHEST. (2020) (9)
- A head and neck cancer intervention for use in survivorship clinics: a protocol for a feasibility study (2016) (9)
- Defining the Impact of Family History on Detection of High-grade Prostate Cancer in a Large Multi-institutional Cohort. (2021) (9)
- Acupuncture for pain and dysfunction after neck dissection: preliminary results of a randomized controlled trial (2008) (9)
- Prostate-specific antigen velocity: new methods, same results, still no evidence of clinical utility. (2013) (9)
- Acupuncture: integration into cancer care. (2006) (9)
- Multiple assessment in quality of life trials: how many questionnaires? How often should they be given? (2006) (9)
- Re: Alberto Briganti, Thomas Wiegel, Steven Joniau, et al. early salvage radiation therapy does not compromise cancer control in patients with pT3N0 prostate cancer after radical prostatectomy: results of a match-controlled multi-institutional analysis. Eur Urol 2012;62:472-87: statistical concerns (2013) (9)
- Androgen deprivation therapy in men with node-positive prostate cancer treated with postoperative radiotherapy. (2020) (9)
- The Acupuncture Trialists— Collaboration: Individual Patient Data Meta-Analysis of Chronic Pain Trials (2009) (9)
- Homoeopathic Oscillococcinum for preventing and treating influenza and influenza-like syndromes. (2006) (9)
- Informing, Reassuring, or Alarming? Balancing Patient Needs in the Development of a Postsurgical Symptom Reporting System in Cancer (2018) (8)
- PSA is dead, long live PSA. (2012) (8)
- Joint pain and falls among women with breast cancer on aromatase inhibitors (2018) (8)
- The alternative health and medicine encyclopedia, James E. Marti. Gale Research, London (1995), xxiii+376pp. £12.99(paper), [available in UK through Routledge], ISBN: 08103 8303 9 (1996) (8)
- Reflections on complementary medicine research in the UK. (1999) (8)
- Prostate cancer polygenic risk score and prediction of lethal prostate cancer (2022) (8)
- Intra‐individual short‐term variability of prostate‐specific antigen and other kallikrein markers in a serial collection of blood from men under evaluation for prostate cancer (2011) (8)
- Association between urinary cytology and pathology for nontransitional cell malignancies of the urinary tract. (2006) (8)
- Herbal medicine (1990) (8)
- Measurements of proteases or protease system components in blood to enhance prediction of disease risk or outcome in possible cancer. (2007) (8)
- THE CONTINUING ROLE OF PROSTATE‐SPECIFIC ANTIGEN AS A MARKER FOR LOCALIZED PROSTATE CANCER: ‘DO NOT THROW THE BABY OUT WITH THE BATH WATER’ (2009) (8)
- Prostate cancer: Why is PSA velocity such a sticky concept? (2013) (8)
- Feasibility study of a clinically-integrated randomized trial of modifications to radical prostatectomy (2012) (8)
- A Personalized Automated Messaging System to Improve Adherence to Prostate Cancer Screening: Research Protocol (2012) (8)
- Value of Intact Prostate Specific Antigen and Human Kallikrein 2 in the 4 Kallikrein Predictive Model: An Individual Patient Data Meta‐Analysis (2018) (8)
- Long-Term Health Outcomes of a Decision Aid: Data from a Randomized Trial of Adjuvant! in Women with Localized Breast Cancer (2009) (7)
- The NIH Methodology Conference: the methodology debate in the United Kingdom during the past ten years. (1995) (7)
- Electronic patient-reported symptom monitoring in patients recovering from ambulatory minimally invasive gynecologic surgery: A prospective pilot study (2020) (7)
- Risk factors for infection after prostate biopsy in the United States. (2019) (7)
- External Evaluation of a Novel Prostate Cancer Risk Calculator (ProstateCheck) Based on Data from the Swiss Arm of the ERSPC. (2016) (7)
- 1783 INDIVIDUALIZED ESTIMATION OF THE BENEFIT OF RADICAL PROSTATECTOMY: DATA FROM SPCG4, THE SCANDINAVIAN RANDOMIZED TRIAL OF RADICAL PROSTATECTOMY (2011) (7)
- Optimal Dissemination of Scientific Manuscripts via Social Media: A Prospective Trial Comparing Visual Abstracts Versus Key Figures in Consecutive Original Manuscripts Published in European Urology. (2022) (7)
- Value of Partial Nephrectomy for Renal Cortical Tumors of cT2 or Greater Stage: A Risk-benefit Analysis of Renal Function Preservation Versus Increased Postoperative Morbidity. (2020) (7)
- A Randomized Controlled Trial Evaluating Electronic Outpatient Symptom Monitoring After Ambulatory Cancer Surgery (2021) (7)
- Basic introduction to research: how not to do research. (2008) (7)
- Responses to the Acupuncture Trialists— Collaboration Individual Patient Data Meta-Analysis (2013) (7)
- Routine Opioid Prescriptions Are Not Necessary After Breast Excisional Biopsy or Lumpectomy Procedures (2020) (7)
- Erectile Function and Sexual Satisfaction: The Importance of Asking About Sexual Desire. (2019) (7)
- A basic introduction to medical research. Part I: What is research and why do it? (1995) (6)
- Complementary medicine and disability (1993) (6)
- Use of a single global assessment to reduce missing data in a clinical trial with follow-up at one year. (2003) (6)
- A pre-specified model based on four kallikrein markers in blood improves predictions of adverse pathology and biochemical recurrence after radical prostatectomy (2020) (6)
- Impact of the radical prostatectomy surgical technique and surgeon experience on freedom from cancer recurrence. (2006) (6)
- Identifying patients with chronic pain who respond to acupuncture: results from an individual patient data meta-analysis (2020) (6)
- A Nationwide Analysis of Risk of Prostate Cancer Diagnosis and Mortality following an Initial Negative Transrectal Ultrasound Biopsy with Long-Term Followup (2022) (6)
- Comparison of Physician-Documented Versus Patient-Reported Collection of Comorbidities Among Patients With Prostate Cancer Upon First Visit to the Urology Clinic. (2018) (6)
- Comparison of Postradical Cystectomy Ileus Rates Using GIA-80 Versus GIA-60 Intestinal Stapler Device. (2018) (6)
- Development and pilot implementation of a remote monitoring system for acute toxicity using electronic patient-reported outcomes (ePROs) for patients undergoing radiation therapy for breast cancer. (2021) (6)
- What conclusions should we draw from the data? (1995) (6)
- Decision Curves, Calibration, and Subgroups. (2017) (6)
- Multi-cohort modeling strategies for scalable globally accessible prostate cancer risk tools (2019) (6)
- Correction: Characteristics of Acupuncture Treatment Associated with Outcome: An Individual Patient Meta-Analysis of 17,922 Patients with Chronic Pain in Randomised Controlled Trials (2013) (6)
- How to improve accrual to clinical trials of symptom control 2: design issues. (2007) (6)
- Can We Improve the Preoperative Prediction of Prostate Cancer Recurrence With Multiparametric MRI? (2019) (6)
- Ensuring Scientific Rigour in Literature Review (1995) (6)
- Complementary medicine, intermediate medicine and the degree of intervention (1994) (6)
- Validation of Patient-Reported Outcomes: A Low Bar. (2019) (6)
- Suitability of outpatient or ambulatory extended recovery cancer surgeries for obese patients. (2019) (6)
- Biopsy Core Features are Poor Predictors of Adverse Pathology in Men with Grade Group 1 Prostate Cancer (2017) (6)
- Re: an empirical evaluation of guidelines on prostate-specific antigen velocity in prostate cancer detection. (2011) (6)
- Re: Comparative effectiveness of prostate cancer treatments: evaluating statistical adjustments for confounding in observational data. (2011) (6)
- Prognostic Model for Predicting Survival in Patients with Disease Recurrence Following Radical Cystectomy. (2015) (6)
- Erratum: Clinical benefits of a multivariate prediction model for bladder cancer: A decision analytic approach (Cancer (2009) 115 (5460-5469)) (2011) (6)
- Surgery confounds biology: The predictive value of stage‐, grade‐ and prostate‐specific antigen for recurrence after radical prostatectomy as a function of surgeon experience (2011) (5)
- Re: Tobias Nordström, Andrew Vickers, Melissa Assel, Hans Lilja, Henrik Grönberg, Martin Eklund. Comparison Between the Four-kallikrein Panel and Prostate Health Index for Predicting Prostate Cancer. Eur Urol 2015;68:139-46. (2018) (5)
- RISK-ADJUSTED ANALYSIS OF POSITIVE SURGICAL MARGINS FOLLOWING LAPAROSCOPIC AND RETROPUBIC RADICAL PROSTATECTOMY (2006) (5)
- Four flawed arguments against prostate-specific antigen screening (and 1 good one). (2015) (5)
- Letter to the editor concerning 'Do prostate cancer risk models improve the predictive accuracy of PSA screening? A meta-analysis'. (2015) (5)
- Establishing a global quality of care benchmark report (2021) (5)
- In Organ-confined Prostate Cancer, Tumor Quantitation Not Found to Aid in Prediction of Biochemical Recurrence (2019) (5)
- Ambulatory Extended Recovery: Safely Transitioning to Overnight Observation for Minimally Invasive Prostatectomy (2015) (5)
- PD30-10 DEFINITIVE AND SUSTAINED INCREASE IN PROSTATE CANCER METASTASES IN THE UNITED STATES (2019) (5)
- Interpreting data from randomized trials: the Scandinavian prostatectomy study illustrates two common errors (2005) (5)
- How Should Molecular Markers and Magnetic Resonance Imaging Be Used in the Early Detection of Prostate Cancer? (2021) (5)
- The trifecta: great concept, lousy statistic (2012) (5)
- Comparative risk-adjusted mortality outcomes following primary surgery, radiation therapy, or androgen deprivation therapy for localized prostate cancer (2011) (5)
- Reducing Systematic Review to a Cut and Paste (2010) (5)
- Kallikrein markers performance in pretreatment blood to predict early prostate cancer recurrence and metastasis after radical prostatectomy among very high‐risk men (2019) (5)
- Phase I study of the combination of anti-GD2 antibody 3F8 and barley-derived (1→3,1→4)-β-D-glucan for patients with resistant neuroblastoma (2007) (5)
- Acupuncture for chemotherapy-induced fatigue: A randomized controlled trial. (2011) (4)
- Toward a rational strategy for prostate cancer screening based on long-term risk of prostate cancer metastases and death: Data from a large, unscreened, population-based cohort followed for up to 30 years. (2011) (4)
- Comparison of Two Methods for Assessing Erectile Function Before Radical Prostatectomy. (2019) (4)
- Literature searching in complementary medicine research. (1995) (4)
- Interfaces for collecting data from patients: 10 golden rules (2020) (4)
- Acupuncture for migraine and chronic tension headache in primary care: a large, pragmatic, randomised trial (2010) (4)
- Researching complementary medicine (2000) (4)
- How to measure quality of life in integrative oncology research. (2006) (4)
- Sexual and Gender Minority Persons' Perception of the Female Sexual Function Index. (2021) (4)
- Three things about Gleason grading that just about everyone believes but that are almost certainly wrong. (2020) (4)
- Prognosis, Effect Modification, and Mediation. (2018) (4)
- The Surgical Learning Curve for Biochemical Recurrence After Robot-assisted Radical Prostatectomy. (2022) (4)
- Assessing the Learning Curve for Prostate Cancer Surgery (2011) (4)
- The Duration of Antibiotics Prophylaxis at the Time of Catheter Removal after Radical Prostatectomy: Clinically-Integrated, Cluster, Randomized Trial. (2021) (4)
- Decision curve analysis in the evaluation of radiology research (2022) (4)
- Complementary and Alternative Cancer Therapies (2003) (4)
- Guidelines for Reporting of Figures and Tables for Clinical Research in Urology. (2020) (4)
- 897 Gender-specific differences in clinicopathologic outcomes following radical cystectomy: An international multi-institutional study of over 8,000 patients (2014) (4)
- Grade Migration of Prostate Cancer in the United States during the last decade. (2022) (4)
- Why acute kidney injury during partial nephrectomy matters. (2020) (4)
- A proposal for teaching critical thinking to students and practitioners of complementary medicine. (1997) (4)
- Assessing Rapidity of Recovery After Cancer Surgeries in a Single Overnight Short-Stay Setting. (2019) (4)
- 1398: Effects of Patient Risk on the Learning Curve for Radical Prostatectomy: Evidence that Recurrence in Organ-Confined Cancer is Largely Related to Inadequate Surgical Technique (2007) (4)
- Data and programming code from the studies on the learning curve for radical prostatectomy (2010) (4)
- Do the effects of acupuncture vary between acupuncturists? Analysis of the Acupuncture Trialists’ Collaboration individual patient data meta-analysis (2020) (4)
- Author response: Tumor copy number alteration burden is a pan-cancer prognostic factor associated with recurrence and death (2018) (4)
- Incorporating Clinical Considerations into Statistical Analyses of Markers: A Quiet Revolution in How We Think About Data. (2016) (4)
- Double-blind, randomized trial of granulocyte-colony stimulating factor (GCSF) versus (v.) placebo during postoperative radiation (RT) for advanced resectable squamous cell head and neck cancer (SCCHN): Impact on mucositis. (2004) (3)
- Racial Disparities in Low-Risk Prostate Cancer. (2019) (3)
- primary care trial of acupuncture for chronic headache in Cost effectiveness analysis of a randomised (2005) (3)
- Asian-American Race and Urinary Continence After Radical Prostatectomy (2020) (3)
- Impact of caregiver overnight stay on postoperative outcomes. (2019) (3)
- Predictive value of preoperative neutrophil-to-lymphocyte ratio in localized prostate cancer: results from a surgical series at a high-volume institution. (2020) (3)
- THE SURGICAL LEARNING CURVE FOR LAPAROSCOPIC COMPARED TO OPEN RADICAL PROSTATECTOMY (2009) (3)
- How to reduce the number of patients needed for randomized trials: a basic introduction. (2001) (3)
- National Health Service funding for complementary medicine research: the NHS acupuncture trials. (1999) (3)
- Counterpoint: Prostate-specific antigen velocity is not of value for early detection of cancer. (2013) (3)
- How to improve accrual to clinical trials of symptom control 1: recruitment strategies. (2007) (3)
- Manifesto: towards a clinically-oriented psychometrics (2017) (3)
- Impact of self-reported data on the acquisition of multi-generational family history and lifestyle factors among women seen in a high-risk breast screening program: a focus on modifiable risk factors and genetic referral (2017) (3)
- Writing Up Clinical Research: A Statistician’s View (2013) (3)
- Reduced 90-day postoperative mortality through geriatric comanagement after cancer surgery. (2019) (3)
- Do Prediction Models Do More Harm Than Good? (2022) (3)
- Against mind-body medicine (1998) (3)
- Polygenic risk scores to stratify cancer screening should predict mortality not incidence (2022) (3)
- Change/Percent Change From Baseline (2014) (3)
- On breakfast and randomised trials (2001) (3)
- Young Age on Starting Prostate-specific Antigen Testing Is Associated with a Greater Reduction in Prostate Cancer Mortality: 24-Year Follow-up of the Göteborg Randomized Population-based Prostate Cancer Screening Trial. (2022) (3)
- Gene-based Confirmatory Germline Testing Following Tumor-only Sequencing of Prostate Cancer. (2022) (3)
- 17: The Concordance between a Systematically Administered Physician Reported Assessment of Function and a Health-Related Quality of Life Instrument (2007) (3)
- Correction to How to interpret a small increase in AUC with an additional risk prediction marker: Decision analysis comes through [Statist. Med. (2015) 33, 22, 3946-3959] DOI: 10.1002/sim.6195 (2014) (3)
- Extended pelvic lymph node dissection in patients with prostate cancer previously treated with surgery for lower urinary tract symptoms (2015) (3)
- Chapter 3 – Inspiration and perspiration: what every researcher needs to know before they start (2002) (3)
- A PANEL OF KALLIKREIN MARKERS CAN REDUCE UNNECESSARY BIOPSY FOR PROSTATE CANCER: DATA FROM THE EUROPEAN RANDOMIZED STUDY OF PROSTATE CANCER SCREENING (ERSPC) IN GOTEBORG, SWEDEN (2008) (3)
- Living proof and the pseudoscience of alternative cancer treatments. (2008) (2)
- A phase I/II trial of a polysaccharide extract from Grifola frondosa (Maitake mushroom) in breast cancer patients (2008) (2)
- Risk Prediction Versus Diagnosis: Preserving Clinical Nuance in a Binary World (2009) (2)
- Assessing the clinical feasibility of implementing a novel assessment of frailty: The electronic Rapid Fitness Assessment in diverse thoracic surgery clinics. (2017) (2)
- 383: Which Definition of PSA Doubling Time or Velocity best Predicts Outcome after Radical Prostatectomy? (2007) (2)
- Prostatectomy in Patients with Oligometastatic Hormone-sensitive Prostate Cancer? Not Yet. (2022) (2)
- PREDICTORS OF URINARY CONTINENCE AFTER CONTEMPORARY RADICAL PROSTATECTOMY (2008) (2)
- Old myths given new voice. The Nuffield report: Researching and evaluating complementary therapies: (1996) (2)
- 986 HOW SOON CAN WE IDENTIFY MEN AT HIGH RISK FOR PROSTATE CANCER DEATH? AN EARLY SURVEILLANCE STRATEGY FOR PROSTATE CANCER (2011) (2)
- What do we mean by "outcome can be predicted"? (2008) (2)
- A randomized trial on pelvic lymph node dissection versus no lymph node dissection at radical prostatectomy: Report of a trial in progress. (2022) (2)
- How to … give a talk at a conference (1997) (2)
- What has to happen before we report radical prostatectomy outcomes of individual surgeons to the public? (2011) (2)
- The Evolution of Complementary and Alternative Medicine (2003) (2)
- A basic introduction to medical research. Part II: An overview of different research methods. (1995) (2)
- Clinically Significant Risk Thresholds in the Management of Primary Cutaneous Melanoma: A Survey of Melanoma Experts (2022) (2)
- Mainstream Acceptance of CAM (2003) (2)
- Learning curve of positive margin rate in laparoscopic radical prostatectomy (2008) (2)
- Predictive value of preoperative neutrophil-to-lymphocyte ratio in localized prostate cancer: results from a surgical series at a high-volume institution (2021) (2)
- Prostate-specific antigen and prostate cancer: prediction, detection and monitoring (Corrigendum) (2008) (2)
- Author ’ s response The use of percentage change from baseline as an outcome in a controlled trial is statistically inefficient (2001) (2)
- 559: Impact of Fellowship Training on Oncological Outcomes after Radical Prostatectomy (2007) (2)
- Homœopathy and disability (1993) (2)
- 590: Viable Germ Cell Tumor (GCT) Identified at Post-Chemotherapy Retroperitoneal Lymph Node Dissection (PC-RPLND): The Significance of Risk Assignment and Adjuvant Chemotherapy (2006) (2)
- Risk of prostate cancer and death after benign transurethral resection of the prostate—A 20‐year population‐based analysis (2022) (2)
- Pharmacogenomics of antioxidant supplementation to prevent age-related macular degeneration (2018) (2)
- Urological cancer: Time for another rethink on prostate cancer screening (2012) (2)
- A SINGLE PSA PREDICTS PROSTATE CANCER UP TO 30 YEARS SUBSEQUENTLY, EVEN IN MEN BELOW AGE 40 (2008) (2)
- Guidelines for Reporting of Figures and Tables for Clinical Research in Urology. (2020) (2)
- 339 A head to head comparison between a 4-kallikrein panel and a [-2]proPSA derivative model (2014) (2)
- Prevalence of High-Risk Prostate Cancer Metastasis to Cloquet’s Ilioinguinal Lymph Node (2022) (2)
- Words of wisdom: Re: Comparative effectiveness of alternative prostate-specific antigen-based prostate cancer screening strategies: model estimates of potential benefits and harms. (2013) (2)
- The lure of the ghetto. (2000) (2)
- Association of frailty with 90-day postoperative mortality & geriatric comanagement among older adults with cancer. (2021) (2)
- 974 PREDICTING PROSTATE BIOPSY OUTCOME IN A SCREENING SETTING PSA, PCA3, A KALLIKREIN PANEL, THE RISKCALCULATOR OR A COMBINATION? ERSPC ROTTERDAM (2010) (2)
- Clinical utility of subclassifying positive surgical margins at radical prostatectomy (2021) (2)
- Acupuncture and the US Food and Drugs Administration: how should complementary therapies be regulated? (1997) (2)
- Improving the specificity of prostate cancer screening for early detection of lethal disease. (2014) (2)
- A systematic review of instrumental variable analyses using geographic region as an instrument. (2017) (2)
- Estimating patient health in prostate cancer treatment counseling (2020) (2)
- 214: Incidence and Risk Factors of Symptomatic DVT in Prostate Cancer Patients Undergoing Laparoscopic Radical Prostatectomy (2006) (2)
- Have urinary function outcomes after radical prostatectomy improved over the past decade? (2021) (2)
- Relationship Between Age, Comorbidity, and the Prevalence of Erectile Dysfunction. (2022) (2)
- Decision analysis of dutasteride use for patients with negative prostate biopsy. (2015) (2)
- 1430: Association of Cysteine-Rich Secretory Protein 3 and Beta-Microseminoprotein with Outcome after Radical Prostatectomy: Evaluation with a Tissue Microarray of 947 Primary Prostate Cancers (2007) (2)
- Prostate-specific antigen velocity in a prospective prostate cancer screening study of men with genetic predisposition (2018) (2)
- Prostate-specific Antigen Density Cutoff of 0.15 ng/ml/cc to Propose Prostate Biopsies to Patients with Negative Magnetic Resonance Imaging: Efficient Threshold or Legacy of the Past? (2022) (2)
- Innovations in Statistical Review at European Urology. (2019) (2)
- Toward Responsible, Informed Decision Making for Prostate Cancer Treatment Decisions. (2019) (2)
- Long-term prediction of prostate cancer diagnosis and death using PSA and obesity related anthropometrics at early middle age: data from the malmö preventive project (2017) (1)
- Correction: Corrigendum: Can we deliver randomized trials of focal therapy in prostate cancer? (2017) (1)
- MRI-Targeted Biopsy for Prostate-Cancer Diagnosis. (2018) (1)
- 1226: Establishing a Minimum Number of Lymph Nodes to be Removed during Radical Cystectomy: Implications for the Necessary Extent of Dissection (2006) (1)
- Assessing the clinical feasibility of electronic Rapid Fitness Assessment (eRFA): A novel geriatric assessment tool for the oncology setting. (2016) (1)
- MP18-15 A MODEL BASED ON FOUR KALLIKREIN MARKERS IN BLOOD IMPROVES THE PREDICTIVE ACCURACY OF ADVERSE PATHOLOGY AND BIOCHEMICAL RECURRENCE AFTER RADICAL PROSTATECTOMY (2019) (1)
- 700 TOTAL HUMAN KALLIKREIN 2 - A POTENTIALLY USEFUL SERUM MARKER OF BONE METASTASIS AND BIOCHEMICAL FAILURE IN PROSTATE CANCER (2009) (1)
- Implementation of an enhanced recovery protocol in patients undergoing mastectomies for breast cancer: an interrupted time-series design (2022) (1)
- The significance of ureteral sampling at radical cystectomy in bladder cancer patients (2005) (1)
- Informed Decision Making About Prostate Cancer Screening (2015) (1)
- Phase 2b trial results of padeliporfin (WST11 or Tookad) vascular-targeted photodynamic therapy for partial gland ablation in men with intermediate-risk prostate cancer. (2021) (1)
- The Clinical Effectiveness of Massage Therapy (1995) (1)
- How should we define patients who are at high risk of death from prostate cancer? (2007) (1)
- Guidelines for Reporting of Figures and Tables for Clinical Research in Urology. (2020) (1)
- Addition of Prostate Volume and Prostate-specific Antigen Density to Memorial Sloan Kettering Cancer Center Prostate Cancer Nomograms (2021) (1)
- MP54-10 COMPARISON BETWEEN LIMITED AND EXTENDED LYMPH NODE DISSECTION FOR PROSTATE CANCER: RESULTS FROM A LARGE, CLINICALLY-INTEGRATED, RANDOMIZED TRIAL (2019) (1)
- Complementary medicine or antagonistic medicine? (1999) (1)
- Dutasteride reduces incident prostate cancer in men after negative prostate biopsy (2010) (1)
- Reply to comparative risk‐adjusted mortality outcomes after primary surgery, radiotherapy, or androgen‐deprivation therapy for localized prostate cancer (2011) (1)
- Use of complementary therapies by women in the South Thames NHS region with a diagnosis of breast cancer: a short report (1998) (1)
- Higher-Order Musical Temporal Structure in Bird Song (2021) (1)
- PD32-04 CAN CONFIRMATORY BIOPSY BE SKIPPED FOR ACTIVE SURVEILLANCE PATIENTS WITH NEGATIVE MRI FINDINGS AND A LOW NUMBER OF POSITIVE CORES ON DIAGNOSTIC BIOPSY? (2015) (1)
- Comprar ABC of Complementary Medicine | M. Dutta | 9781405136570 | Wiley (2009) (1)
- HOW COMMON IS LATE RECURRENCE AFTER RADICAL PROSTATECTOMY (2008) (1)
- Response to “Comment on: Decisional Conflict, Regret, and the Burden of Rational Decision Making” (2017) (1)
- Practice Patterns in Reporting Tertiary Grades at Radical Prostatectomy: Survey of a Large Group of Experienced Urologic Pathologists. (2019) (1)
- Statistical Considerations for Patient Selection and Triggers for Intervention in Active Surveillance (2012) (1)
- 856 Reducing the number of prostate biopsies – validation of a four kallikrein panel to predict prostate cancer in a population-based referral cohort (2013) (1)
- Natural Therapies Database UK, in: Bodywork, vol 1 (1994), Quarterly. £90 pa; £25 per issue (47 Ashby Avenue, Chessington, Surrey, KT9 2BT, UK) (1995) (1)
- Words of wisdom. Re: Prostate cancer screening in the randomized prostate, lung, colorectal, and ovarian cancer screening trial: mortality results after 13 years of follow-up. (2012) (1)
- 421 THE SURGICAL LEARNING CURVE FOR ARTIFICIAL URINARY SPHINCTER PROCEDURES COMPARED TO TYPICAL SURGEON EXPERIENCE (2011) (1)
- INTERPRETING PATIENT‐REPORTED URINARY AND SEXUAL FUNCTION OUTCOMES ACROSS MULTIPLE VALIDATED INSTRUMENTS: MP93‐08 (2017) (1)
- Comparison of acupuncture with other physical treatments for pain caused by osteoarthritis of the knee: a network meta-analysis (2017) (1)
- 2023 ARE THE RIGHT MEN BEING SCREENED? TRENDS IN PSA SCREENING IN THE UNITED STATES (US) (2011) (1)
- Recent review of research on a technique for treating cancer. (2004) (1)
- Four‐hundredfold overestimation of biopsy mortality (2013) (1)
- MP38-06 COMPARING LONG-TERM ONCOLOGIC OUTCOMES BETWEEN OPEN RADICAL CYSTECTOMY AND ROBOT-ASSISTED LAPAROSCOPIC RADICAL CYSTECTOMY: A RANDOMIZED CLINICAL TRIAL (2016) (1)
- Acupuncture for hypertension: a tale of two trials. From the perspective of the statistician--Andrew Vickers, New York, NY, USA. (2007) (1)
- Accommodating heterogeneous missing data patterns for prostate cancer risk prediction (2021) (1)
- A qualitative analysis of caregiver burden during the recovery process in ambulatory cancer surgery (2022) (1)
- MP53-17 INCREASING INCIDENCE OF INFECTIONS AFTER PROSTATE BIOPSY IN THE UNITED STATES (2019) (1)
- Concordance between patient-reported and physician-reported sexual function after radical prostatectomy. (2017) (1)
- MP46-15 PROSPECTIVE VALIDATION OF THE FOUR KALLIKREIN PANEL IN ACADEMIC CLINICAL PRACTICE (2018) (1)
- MP46-04 RESULTS OF THE PCM-204 PHASE 2B TRIAL OF PARTIAL-GLAND ABLATION FOR MEN WITH INTERMEDIATE-RISK PROSTATE CANCER WITH PADELIPORFIN (WST11 OR TOOKAD) VASCULAR-TARGETED PHOTODYNAMIC THERAPY (2021) (1)
- Comparison of Objective Measures of Trismus and Salivation With Patient-reported Outcomes Following Treatment for Head and Neck Cancer. (2022) (1)
- A basic introduction to medical research. Part III: What can the practitioner do? (1995) (1)
- care: large, pragmatic, randomised trial Acupuncture for chronic headache in primary (2004) (1)
- Acupuncture for Chronic PainIndividual Patient Data Meta-analysis (2012) (1)
- Applying decision curve analysis to spine surgery (2021) (1)
- Complementary medicine and disability: Alternatives for people with disabling conditions (1993) (1)
- 1607: Longitudinal Evaluation of Molecular PSA Isoforms and Human Glandular Kallikrein 2 in Predicting Biochemical Failure following Radical Prostatectomy (2007) (1)
- 243 EMPIRICAL ESTIMATE OF THE LEAD TIME DISTRIBUTION FOR PROSTATE CANCER BASED ON TWO INDEPENDENT REPRESENTATIVE COHORTS OF MEN NOT SUBJECT TO PSA-SCREENING (2010) (1)
- UTILITY OF DIGITAL RECTAL EXAMINATION (DRE) IN DETECTION OF CLINICALLY SIGNIFICANT PROSTATE CANCER: AGE AND PROSTATE‐SPECIFIC ANTIGEN (PSA)‐BASED ANALYSIS: PD07‐05 (2017) (1)
- Fundamentals of Complementary and Alternative Medicine, Marc S. Micozzi (Ed.). Churchill Livingstone, Edinburgh (1996), 0-443-05355-3 (1996) (1)
- Decision Curve Analysis for Personalized Treatment Choice between Multiple Options (2022) (1)
- The association between modifiable perioperative parameters and renal function after nephrectomy (2021) (1)
- Blood prostate-specific antigen by volume of benign, Gleason pattern 3 and 4 prostate tissue. (2022) (1)
- MP39-16 DETECTING HIGH GRADE CANCER AND REDUCING PROSTATE BIOPSY AMONG PLCO PARTICIPANTS USING A PRE-SPECIFIED STATISTICAL MODEL BASED ON LEVELS OF FOUR KALLIKREIN MARKERS AND MICROSEMINOPROTEIN-BETA IN BLOOD (2016) (1)
- Association of Family History of Cancer with Clinical and Pathological Outcomes for Prostate Cancer Patients on Active Surveillance (2022) (1)
- Radical prostatectomy versus observation for prostate cancer. (2012) (1)
- Reply: To PMID 24824406. (2014) (1)
- 1258: Utility of Assessment of Ureteral Margins during Radical Cystectomy for Urothelial Cancer (2006) (1)
- Inaccurate description of staged consent. (2022) (1)
- Risk-based surveillance after surgical treatment of renal cell carcinoma (2018) (1)
- Reply to Re: The Memorial Sloan Kettering Cancer Center Recommendations for Prostate Cancer Screening. (2016) (1)
- Do not treat Bill Gates for prostate cancer! Algorithmic bias and causality in medical prediction (2023) (1)
- 596 CANCER CONTROL DOES NOT REQUIRE SACRIFICE OF FUNCTIONAL OUTCOMES AFTER RADICAL PROSTATECTOMY: ANALYSIS OF HETEROGENEITY BETWEEN SURGEONS AT A SINGLE CANCER CENTER (2010) (1)
- A systematic literature review of life expectancy prediction tools for localized prostate cancer patients (2015) (1)
- MP06-01 INCIDENCE AND IMPACT OF VENOUS THROMBOEMBOLISM IN RADICAL CYSTECTOMY PATIENTS UNDERGOING PRE-OPERATIVE CHEMOTHERAPY FOR MUSCLE-INVASIVE BLADDER CANCER (2016) (1)
- The general practitioners' complementary medicine versus evidence-based medicine. (2001) (1)
- If something looks too good to be true, it probably is (2013) (1)
- Memorial Sloan Kettering-Frailty Index (MSK-FI): Validation and its relationship with postoperative outcomes of older survivors of cancer. (2018) (1)
- 616: Variations Among Experienced Surgeons and Cancer Control Rates after Radical Prostatectom (2007) (1)
- PROSTATE SPECIFIC ANTIGEN LEVEL AT AGE 60 AND DEATH FROM PROSTATE CANCER (2009) (1)
- Patient accrual and understanding of informed consent in a two-stage consent design (2021) (1)
- Words of wisdom: Re: Population-based patterns and predictors of prostate-specific antigen screening among older men in the United States. (2011) (1)
- Survivor feedback on a late effects-oriented survivorship care plan for head and neck cancer. (2017) (1)
- Safety of massage and aromatherapy (1996) (1)
- 1986 AN EMPIRICAL EVALUATION OF THE NATIONAL CANCER CENTER NETWORK GUIDELINES ON PROSTATE SPECIFIC ANTIGEN VELOCITY IN PROSTATE CANCER DETECTION (2010) (1)
- Comments on “Net reclassification index at event rate: Properties and relationships” (2019) (1)
- Research on massage (1996) (1)
- Laparoscopy: Chronic kidney disease after nephrectomy in patients with renal cortical tumours: A retrospective cohort study - Commentary (2007) (1)
- 982 LIFETIME RISK OF DEATH FROM PROSTATE CANCER PREDICTED BY KALLIKREIN MARKERS IN BLOOD TAKEN AT AGE 60 (2010) (1)
- 1202 CAN AN EARLY PSA RULE OUT SUBSEQUENT ADVANCED PROSTATE CANCER? LONG TERM RISK OF ADVANCED CANCER IN MEN WITH LOW PSA LEVELS AT AGE BELOW 50 (2011) (1)
- Shared Medical Appointments for Prostate Cancer Active Surveillance Followup Visits (2021) (1)
- 1085 REVERSE STAGE MIGRATION AT A TERTIARY CARE CENTER: ESCALATING RISK IN MEN UNDERGOING RADICAL PROSTATECTOMY ASSOCIATED WITH INCREASING USE OF ACTIVE SURVEILLANCE (2011) (1)
- PD52-08 CHANGES IN BLOOD LEVELS OF PROSTATE KALLIKREIN-RELATED AND MICROSEMINOPROTEIN-BETA MARKER LEVELS FOLLOWING 5ARI THERAPY: DATA FROM 500 PCPT-PARTICIPANTS (2020) (1)
- Oncologic Outcomes of Total Length Gleason Pattern 4 on Biopsy in Men with Grade Group 2 Prostate Cancer (2022) (1)
- 813 Time to disease recurrence is a strong predictor of cancer-specific mortality in upper tract urothelial carcinoma (2013) (1)
- Does Prostate-Specific Antigen Screening Do More Good Than Harm?: Depends on How You Do It. (2016) (1)
- Five genetic variants associated with prostate cancer. (2008) (1)
- Phase II designs for anticancer botanicals and supplements. (2009) (1)
- Reviewing the evidence for homoeopathy (1996) (1)
- Feasibility of a geriatric comanagement (GERICO) pilot program for patients 75 and older undergoing radical cystectomy. (2022) (1)
- Commentary on Aschmann et al: How do we incorporate harms in analyses of randomized trials? (2022) (1)
- Response to Chappell (2018) (1)
- 1512: Age Adjusted Charlson Comorbidity Score is Associated with Treatment Decisions and Clinical Outcomes for Patients Undergoing Radical Cystectomy for Bladder Cancer (2007) (1)
- Screening for Prostate Cancer (2012) (1)
- Patient-Reported Financial Toxicity Following Definitive Radiation Therapy for Localized Prostate Cancer. (2021) (0)
- Cardiovascular risk factors, radiation therapy, and myocardial infarction among lymphoma survivors (2022) (0)
- Does the I-PSS Accurately Assess Urinary Function in Prostate Cancer Patients? Evidence From a Study of Nursing Verification of Patient Answers. (2021) (0)
- Orally taken remedies (1993) (0)
- 1735 THE UTILITY OF A PANEL OF KALLIKREIN MARKERS TO PREDICT PROSTATE CANCER: ASSESSMENT ON AN UNSCREENED COHORT (2010) (0)
- PD60-11 PROGNOSTIC SIGNIFICANCE OF PERIVESICAL LYMPH NODE STATUS IN PATIENTS WITH MUSCLE-INVASIVE BLADDER CANCER UNDERGOING RADICAL CYSTECTOMY (2020) (0)
- 160 Predictors of Worsening Erectile Function in Men With Functional Erections Early After Radical Prostatectomy (2019) (0)
- Reply to K.P. Weinfurt et al. (2020) (0)
- Editorial comment. (2011) (0)
- MP60-10 SHOULD SCREENING FOR PROSTATE CANCER START BEFORE THE AGE OF 55? (2015) (0)
- MP79-20 ASSESSING THE OPTIMAL TIMING OF POSTOPERATIVE TREATMENTS AFTER RADICAL PROSTATECTOMY IN PATIENTS WITH NODE-POSITIVE PROSTATE CANCER: RESULTS FROM A LARGE, MULTI-INSTITUTIONAL SERIES (2020) (0)
- PRS37 ASSOCIATION OF PATIENT-REPORTED INHALER SATISFACTION WITH PHYSICIAN-PERCEIVED COMPLIANCE WITH ASTHMA TREATMENT—RESULTS OF A CROSS-SECTIONAL STUDY IN FIVE EUROPEAN COUNTRIES (2010) (0)
- A Last Word from the Original Author (2000) (0)
- Biomarker Evaluation and Clinical Development (2020) (0)
- 850 A prediction based on levels of four kallikrein markers in blood improves preoperative prediction of indolent versus (2013) (0)
- ' s response to reviews Title : Examining assumptions regarding valid electronic monitoring of medication therapy : development of a validation framework and its application on a European sample of kidney transplant patients (2007) (0)
- MP14-09 UNEXPECTED LONG-TERM IMPROVEMENTS IN URINARY AND ERECTILE FUNCTION IN A LARGE COHORT OF MEN WITH SELF-REPORTED OUTCOMES FOLLOWING RADICAL PROSTATECTOMY (2015) (0)
- The contribution of pre-existing cardiovascular (CV) risk factors to the risk of stroke or heart attack among non-Hodgkin lymphoma (NHL) survivors. (2017) (0)
- MP67-13 COMPARISON OF MORBIDITY BETWEEN LIMITED AND EXTENDED PELVIC LYMPH NODE DISSECTION FOR PROSTATE CANCER: RESULTS FROM A LARGE, CLINICALLY-INTEGRATED, RANDOMIZED TRIAL (2020) (0)
- 1882: Diagnostic Accuracy of Prostate-Specific Antigen Testing in Unscreened Men: Results from the European Randomized Study of Prostate Cancer Screening in Göteborg, Sweden (2007) (0)
- Appendix C. Contributors (2000) (0)
- Does ‘insufficient evidence of benefit’ mean ‘sufficient evidence of no benefit’? (1996) (0)
- Table of Contents (2016) (0)
- MP74-10 VARIATION OF SERUM PROSTATE-SPECIFIC ANTIGEN LEVELS FOR MEN WITH PROSTATE CANCER MANAGED WITH ACTIVE SURVEILLANCE (2014) (0)
- CAM Therapies and Practitioners (2003) (0)
- INDEPENDENT REPLICATION OF A FOUR KALLIKREIN PANEL TO DETECT PROSTATE CANCER: DATA FROM THE EUROPEAN RANDOMIZED STUDY OF PROSTATE CANCER SCREENING IN ROTTERDAM, NETHERLANDS (2009) (0)
- Acupuncture for breast cancer related lymphedema: A randomized controlled trial. (2017) (0)
- Reply by Authors. (2023) (0)
- Correction: Estimating patient health in prostate cancer treatment counseling (2022) (0)
- Vickers, A. J. (2008), Decision Analysis for the Evaluation of Diagnostic Test Prediction Models, and Molecular Models, The American Statistician, 62, 314-320: Comment and Reply (2009) (0)
- MP12-05 PROSTATE CANCER ANXIETY IN MEN UNDERGOING ACTIVE SURVEILLANCE. FINDINGS FROM A LARGE PROSPECTIVE COHORT STUDY (2018) (0)
- Letter to the Editor (2004) (0)
- Against individualistic medicine (1998) (0)
- Frailty based on the Memorial Sloan Kettering Frailty Index is associated with surgical decision making, clinical trial participation, and overall survival among older women with ovarian cancer (2020) (0)
- Prostate-specific antigen and prostate cancer: Prediction, detection and monitoring (Corrigendum) (Nature Reviews Cancer (2008) 8, (268-278)) (2008) (0)
- Reply from Authors re: Riccardo Bartoletti. Prostate-Specific Antigen Dynamics and Prostate Cancer Diagnosis. Eur Urol 2009;56:761–2 (2009) (0)
- How to decide on complementary healthcare (1993) (0)
- 862: Comparative Evaluation of Free and Total Forms of Serum Human Glandular Kallikrein 2 and Prostrate Specific Antigen: Which Marker Should we Trust for Prediction of Locally Advanced and Recurrent Prostate Cancer? (2006) (0)
- Prostate Cancer: Epidemiology & Natural History IIMP09-19 CLINICAL FINDINGS AND TREATMENT OUTCOMES IN PATIENTS WITH EXTRAPROSTATIC EXTENSION IDENTIFIED ON PROSTATE BIOPSY (2016) (0)
- MP39-09 PROPERTIES OF THE FOUR KALLIKREIN PANEL FOR PREDICTION OF PROSTATE BIOPSY OUTCOME IN MEN WITH HIGH PSA (10-25 NG /ML) (2016) (0)
- MP57-16 THE ASSOCIATION BETWEEN MODIFIABLE ANESTHETIC PARAMETERS AND RENAL FUNCTION AFTER NEPHRECTOMY (2020) (0)
- Reviewing the literature (1997) (0)
- COMPARISON OF THE LEARNING CURVES FOR OPEN AND LAPAROSCOPIC RADICAL PROSTATECTOMY: AN INTERNATIONAL MULTICENTER STUDY (2009) (0)
- Impact of previous depression on the risk of suicide among prostate cancer patients (2023) (0)
- Androgen deprivation therapy for biochemical recurrence in patients with seminal vesicle invasion after radical prostatectomy (2005) (0)
- Where to look for information (1993) (0)
- Relative contribution of androgen deprivation therapy in combination with adjuvant radiotherapy for node-positive prostate cancer (2021) (0)
- Corrigendum to "Effects of Magnetic Resonance Imaging Targeting on Overdiagnosis and Overtreatment of Prostate Cancer" [Eur Urol 2021;80:567-72]. (2022) (0)
- Assessing Quality and Safety of an Advanced Practice Provider-led Active Surveillance Clinic for Men with Prostate Cancer. (2021) (0)
- Corrigendum to definitive and sustained increase in prostate cancer metastases in the United States. (2022) (0)
- VALUE OF PSA VELOCITY FOR PREDICTING BIOPSY OUTCOME IN PREVIOUSLY SCREENED MEN PARTICIPATING IN THE EUROPEAN RANDOMIZED STUDY OF PROSTATE CANCER SCREENING (ERSPC) (2008) (0)
- 2059 RELATIVE RISK OF POSITIVE PROSTATE BIOPSY VS. PROSTATE CANCER MORTALITY BY PSA LEVEL AT AGE 60 (2013) (0)
- Placing Acupuncture in Perspective—Reply (2013) (0)
- MP03-01 ROBOT-ASSISTED RADICAL CYSTECTOMY WITH EXTRACORPOREAL URINARY DIVERSION DOES NOT INCREASE URETEROENTERIC STRICTURE RATE: OUTCOMES FROM A RANDOMIZED TRIAL COMPARING OPEN VERSUS ROBOTIC CYSTECTOMY (2022) (0)
- COMBINING 4KSCORE AND MRI FOR PROSTATE BIOPSY DECISION MAKING: PD40‐08 (2017) (0)
- MP64-08 IS THERE A LIMIT TO EXPANDING THE INDICATIONS OF PARTIAL NEPHRECTOMY TO LARGER TUMORS? - A RISK-BENEFIT ANALYSIS. (2014) (0)
- A FOUR‐KALLIKREIN PANEL IN PREDICTING HIGH‐GRADE PROSTATE CANCER ON BIOPSY: AN INDEPENDENT REPLICATION FROM THE FINNISH SECTION OF THE EUROPEAN RANDOMIZED STUDY OF SCREENING FOR PROSTATE CANCER.: PD40‐06 (2017) (0)
- MP41-07 LONGITUDINAL QUALITY OF LIFE EVALUATION AFTER RADICAL CYSTECTOMY: RESULTS OF A PROSPECTIVE STUDY (2021) (0)
- ONCOLOGICAL OUTCOME AFTER LAPAROSCOPIC RADICAL PROSTATECTOMY: 10 YEARS EXPERIENCE (2008) (0)
- Complementary medicine and the Journal of the American Medical Association (1999) (0)
- Reply from Authors re: Michael W. Kattan, Thomas A. Gerds. Stages of Prediction Model Comparison. Eur Urol 2012;62:597–9 (2012) (0)
- What to expect from complementary healthcare (1993) (0)
- Acupuncture, Counselling or Usual Care for Depression (ACUDep): a randomised controlled trial (2017) (0)
- Study protocol for a prospective, multi-centered randomized controlled trial comparing pelvic fascia-sparing radical prostatectomy with conventional robotic-assisted prostatectomy: The PARTIAL trial. (2023) (0)
- New Prognostic Markers: The Pathway from Research to Clinical Practice. (2009) (0)
- Aromatherapy again. (2000) (0)
- PD03-07 IMPROVED RECOVERY OF ERECTILE FUNCTION IN YOUNGER MEN AFTER RADICAL PROSTATECTOMY: DOES IT JUSTIFY IMMEDIATE INTERVENTION IN LOW-RISK PROSTATE CANCER PATIENTS? (2016) (0)
- MP75-06 EXAMINING RACIAL DIFFERENCES IN URINARY CONTINENCE FOLLOWING RADICAL PROSTATECTOMY (2023) (0)
- 1933 NATION-WIDE, INCIDENCE-BASED ANALYSIS OF PROSTATE CANCER MORTALITY IN COUNTIES WITH HIGH VERSUS LOW RATES OF PSA TESTING IN SWEDEN (2013) (0)
- 2nd TwiCs symposium summary (2017) (0)
- Principles of Complementary and Alternative Medicine for Cancer (2006) (0)
- PD03-06 GRADE MIGRATION OF PROSTATE CANCER AT DIAGNOSIS FOLLOWING THE US PREVENTIVE SERVICES TASK FORCE RECOMMENDATIONS ON PROSTATE CANCER SCREENING (2022) (0)
- PLEASE DON’T TALK BAD ABOUT GOOD OLD AUNT ANOVA!: A REPLY TO A.J. VICKERS’ CRITIQUE: RESPONSE (2006) (0)
- Automating Treatment Summary Development Using Electronic Billing Information: A Pilot Study of Survivors of Head and Neck Cancer. (2019) (0)
- 1002: The Impact of Time from Biopsy to Surgery on Biochemical Recurrence Following Radical Prostatectomy for Clinically Localized Prostate Cancer (2005) (0)
- PD64-09 THE FOUR-KALLIKREIN DISCRIMINATES PROSTATE CANCER AND AGGRESSIVE DISEASE IN A MULTIETHNIC POPULATION (2019) (0)
- A pre-specified statistical model based on four kallikrein markers in blood to predict advanced pathology on radical prostatectomy. (2018) (0)
- ' s response to reviews Sexual behavior and awareness of Chinese university students in transition with implied risk of Title : sexually transmitted diseases and HIV infection : A cross-sectional study (2006) (0)
- Table 76-2, Herbal Products with Serious Toxic Effects (2003) (0)
- 1950 IMPACT OF EXTENDED PELVIC LYMPH NODE DISSECTION ON NOMOGRAM PREDICTION OF LYMPH NODE INVOLVEMENT DURING RADICAL PROSTATECTOMY (2010) (0)
- Cost-effectiveness of non-pharmacological adjunct treatments for patients with osteoarthritis of the knee (2017) (0)
- COMPARATIVE ASSESSMENT OF FREE AND TOTAL FORMS OF SERUM HUMAN GLANDULAR KALLIKREIN 2 AND PROSTRATE SPECIFIC ANTIGEN FOR PREDICTION OF LOCALLY ADVANCED AND RECURRENT PROSTATE CANCER (2006) (0)
- 444 Variation between experienced surgeons in oncological and functional outcome after prostatectomy. A comparison between open and robotic surgeons in the Swedish LAPPRO study (2016) (0)
- Abstract PR01: The four-kallikrein panel discriminates prostate cancer and aggressive disease in a multiethnic population (2020) (0)
- Removing the Designation of Cancer from Grade Group 1 Disease Will Do More Good than Harm. (2022) (0)
- Editorial comment on: Impact of surgical volume on the rate of lymph node metastases in patients undergoing radical prostatectomy and extended pelvic lymph node dissection for clinically localized prostate cancer. (2008) (0)
- Cancer, Unproven Therapies, and Magic (2000) (0)
- Patient Perceptions of a Decision Support Tool for Men with Localized Prostate Cancer (2023) (0)
- Individual patient data meta-analysis of older adults suffering from chronic pain (2015) (0)
- A rapid grasp of the fundamentals (2004) (0)
- 276 Baseline Characteristics of Treated and Untreated Patients with Peyronie’s Disease (PD) (2019) (0)
- Reply to Michael Froehner and Manfred P. Wirth's Letter to the Editor re: Andrew Vickers, Caroline Bennette, Gunnar Steineck, et al. Individualized Estimation of the Benefit of Radical Prostatectomy from the Scandinavian Prostate Cancer Group Randomized Trial. Eur Urol 2012;62:204–9 (2012) (0)
- MP11-12 ARE WE IMPROVING ERECTILE FUNCTION RECOVERY AFTER RADICAL PROSTATECTOMY? (2018) (0)
- Decreasing postoperative opioid prescriptions in ambulatory extended recovery patients. (2019) (0)
- MP12-16 THE DURATION OF ANTIBIOTICS PROPHYLAXIS AT THE TIME OF CATHETER REMOVAL AFTER RADICAL PROSTATECTOMY (2020) (0)
- 1139: Risk Adjusted Analysis of Positive Surgical Margins Following Laparoscopic and Retropubic Radical Prostatectomy (2006) (0)
- MP40-09 RE-ENGINEERING THE INTERNATIONAL INDEX OF ERECTILE FUNCTION: EVALUATION OF A LARGE CLINICAL DATA SET (2019) (0)
- PD10-03 HRQOL AFTER ROBOTIC-ASSISTED VERSUS OPEN RADICAL CYSTECTOMY: ANALYSIS OF A RCT (2022) (0)
- De Lange de Klerk et al.'s Study on Homeopathy (1995) (0)
- EVALUATION OF CANCER CONTROL AFTER OPEN AND LAPAROSCOPIC RADICAL PROSTATECTOMY: 10-YEAR EXPERIENCE (2009) (0)
- CAM Practitioners and Practices (2003) (0)
- Association of smoking history on health-related quality of life in patients undergoing radical cystecomy. (2023) (0)
- Differential levels of serum PSA related to volume of benign, Gleason pattern 3 and pattern 4 prostate tissue. (2021) (0)
- The role of MRI and PET/CT in the primary staging of newly diagnosed prostate cancer: a systematic review of the literature (2021) (0)
- MP50-01 SURVIVAL ANALYSIS OF PATIENTS WITH NODE POSITIVE PROSTATE CANCER AFTER RADICAL PROSTATECTOMY COMPARING OBSERVATION VS. ADJUVANT ANDROGEN DEPRIVATION THERAPY ALONE VS. ADJUVANT ANDROGEN DEPRIVATION PLUS EXTERNAL BEAM RADIATION THERAPY. (2016) (0)
- MP77-11 THE ONCOLOGIC RISK OF MRI-TARGETED AND SYSTEMATIC CORES IN PATIENTS TREATED WITH RADICAL PROSTATECTOMY (2023) (0)
- 471: Biopsy Gleason 8-10 Prostate Cancer: Incidence of Downgrading and Outcome (2005) (0)
- MP43-04 COMPARISON OF 4K SCORE, PROSTATE HEALTH INDEX, AND PSA DENSITY IN ACTIVE SURVEILLANCE (2022) (0)
- Characterization of Symptoms after Radical Prostatectomy and Their Relation to Postoperative Complications (2021) (0)
- Abstract P5-19-02: Withdrawn (2018) (0)
- MP39-13 BASELINE PROSTATE-SPECIFIC ANTIGEN (PSA) LEVELS IN MIDLIFE PREDICT TOTAL AND AGGRESSIVE PROSTATE CANCER IN AFRICAN-AMERICAN MEN (2016) (0)
- Complementary medicine research: an international perspective (1994) (0)
- The therapeutic use of massage and aromatherapy: an overview (1996) (0)
- Reply to: “Ketorolac Following Mastectomy: Is There an Increased Risk of Reoperation?” (2021) (0)
- Risk of prostate-cancer death at 20 years stratified by midlife PSA and a panel of four kallikrein markers from a representative cohort of 11,506 healthy unscreened men aged 45-74 (2017) (0)
- 734: Patients Undergoing Radical Nephrectomy for Small Renal Cortical Tumors are at Increased Risk for Developing Chronic Renal Insufficiency (2006) (0)
- of Screening for Prostate Cancer , Rotterdam StudyRecent Screening : Data from the European Randomized A Four-Kallikrein Panel Predicts Prostate Cancer in Men with (2010) (0)
- PD64-11 THE PRACTICAL POLYGENIC RISK SCORE IS ASSOCIATED WITH PROSTATE CANCER MORTALITY INDEPENDENT OF PSA BUT HAS LOW PREDICTIVE VALUE (2019) (0)
- Racism Does Not Cause Prostate Cancer, It Causes Prostate Cancer Death. (2023) (0)
- Gesellschaftsmitteilungen European Society for Classical Natural Medicine (1999) (0)
- Letrozole and tamoxifen as safer ovarian stimulants in women undergoing embryo cryopreservation for fertility preservation before breast cancer chemotherapy: A prospective controlled trial (2005) (0)
- Ambulatory cancer care electronic symptom self-reporting (ACCESS) for surgical patients: A randomized controlled trial. (2018) (0)
- ASO Visual Abstract: Clinically Significant Risk Thresholds in the Management of Primary Cutaneous Melanoma: A Survey of Melanoma Experts (2022) (0)
- Using patient-reported outcomes measures to tailor care for complex cancer survivors: A feasibility study of HN-STAR. (2018) (0)
- Comparison of erectile function recovery between limited and extended pelvic lymph node dissection for prostate cancer: Results from a large, clinically-integrated, randomized trial (2020) (0)
- 1101: Factors Associated with Clinical Evident Thromboembolic Events Following Nephrectomy (2006) (0)
- Reply by Authors. (2020) (0)
- Preoperative glucose in surgical oncology patient is not associated with postoperative outcomes after adjustment for frailty. (2023) (0)
- Acupuncture in Cancer Patient Care (2006) (0)
- A SYSTEMATIC REVIEW OF INSTRUMENTAL VARIABLE ANALYSES USING GEOGRAPHIC REGION AS AN INSTRUMENT IN PROSTATE CANCER STUDIES: MP47‐05 (2017) (0)
- COMPLEMENTARY CANCER THERAPIES: COMBINING TRADITIONAL AND ALTERNATIVE APPROACHES FOR THE BEST POSSIBLE OUTCOME (2003) (0)
- European Urology: serving our readership through systematic peer review, use of reporting standards, and encouragement of postpublication review. (2015) (0)
- V475 MODIFICATION OF APICAL DISSECTION TECHNIQUE IN LAPAROSCOPIC RADICAL PROSTATECTOMY (2010) (0)
- Research on aromatherapy (1996) (0)
- Guidelines for authors of books and papers on complementary medicine. (1999) (0)
- Relationship Between Clinician-Measured Health Outcomes And Patient-Reported Outcomes Following Head Neck Radiation Therapy (2023) (0)
- Assessment of Patient-Reported Outcomes in Patients With Anal Squamous-Cell Cancer Undergoing Combined Modality Therapy (2022) (0)
- The association between perioperative frailty and ability to complete a web-based geriatric assessment among older adults with cancer. (2022) (0)
- Salvage radical prostatectomy: Oncological outcomes from a large retrospective cohort study (2020) (0)
- Reply to comparative risk‐adjusted mortality outcomes after primary surgery, radiotherapy, or androgen‐deprivation therapy for localized prostate cancer (0)
- MP48-05 COMPARATIVE OUTCOMES OF GLEASON GRADE 2 AND 3 PROSTATE CANCER ON INITIAL VERSUS CONFIRMATORY BIOPSY: IMPLICATIONS FOR ACTIVE SURVEILLANCE (2019) (0)
- PROSTATE‐SPECIFIC ANTIGEN (PSA) LEVELS IN MEN AGED 60 TO 70 AND DEVELOPMENT OF LETHAL PROSTATE CANCER OVER 30 YEARS: IMPLICATIONS FOR RISK‐STRATIFIED SCREENING: MP38‐09 (2017) (0)
- 2060 EMPIRICAL ESTIMATES OF PROSTATE CANCER OVERDIAGNOSIS BY AGE (2013) (0)
- MP72-01 A RANDOMIZED CONTROLLED TRIAL (RCT) OF ONE-STAGE OR A NOVEL TWO-STAGE CONSENT IN MEN OFFERED A BRIEF MIND-BODY INTERVENTION DURING PROSTATE BIOPSY (2023) (0)
- Assessment of Prostate Cancer Patients’ Understanding of the IPSS Questionnaire (2023) (0)
- Editorial comment. (2012) (0)
- PROSTATE CANCER MORTALITY OUTCOMES FOLLOWING SURGERY, RADIATION THERAPY, OR ANDROGEN DEPRIVATION THERAPY FOR PROSTATE CANCER: A RISK-ADJUSTED ANALYSIS OF A LARGE, MULTICENTER COHORT (2009) (0)
- Individual patient data meta-analysis of discrimination of the four kallikrein panel associated with the inclusion of prostate volume. (2021) (0)
- LBA02-12 MRI-GUIDED FOCUSED ULTRASOUND (MRgFUS) FOCAL THERAPY FOR INTERMEDIATE-RISK PROSTATE CANCER: FINAL RESULTS OF A PHASE IIB MULTICENTER STUDY (2021) (0)
- Corrigendum re "Problems with Numbers in Decision Aids for Prostate-specific Antigen Screening: A Critical Review" [Eur Urol 2021;79:330-3]. (2021) (0)
- INCORPORATION OF HUMAN GLANDULAR KALLIKREIN 2 INTO A STANDARD NOMOGRAM TO PREDICT BIOCHEMICAL RECURRENCE FOLLOWING RADICAL PROSTATECTOMY. SIGNIFICANT ADVANTAGE FOR MEN WITH A PRE-TREATMENT PSA ≤ 10ng/ml (2008) (0)
- Movement and stillness: the disciplines (1993) (0)
- PI-02 A SYSTEMATIC APPROACH TO DISCUSSING ACTIVE SURVEILLANCE TO PATIENTS WITH LOW-RISK PROSTATE CANCER (2016) (0)
- INCIDENCE AND RISK FACTORS OF SYMPTOMATIC DEEP VENOUS THROMBOSIS IN PROSTATE CANCER PATIENTS UNDERGOING LAPAROSCOPIC RADICAL PROSTATECTOMY (2006) (0)
- Erratum: Evaluation of molecular forms of PSA and human kallikrein 2 in predicting biochemical failure following radical prostatectomy (International Journal of Cancer (2009) 125 (659-663) DOI:10.1002/ijc.23983) (2010) (0)
- The National Cancer Institute's Conference on Acupuncture for Symptom Management in Oncology (2017) (0)
- SURGERY AS A CONFOUNDER OF BIOLOGY: THE PREDICTIVE VALUE OF STAGE, GRADE AND PROSTATE-SPECIFIC ANTIGEN (PSA) FOR RECURRENCE IS A FUNCTION OF SURGEON EXPERIENCE (2008) (0)
- Reply to Francesco Montorsi, Giorgio Gandaglia, and Alberto Briganti's Letter to the Editor re: Andrew J. Vickers. Effects of Magnetic Resonance Imaging Targeting on Overdiagnosis and Overtreatment of Prostate Cancer. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2021.06.026. (2021) (0)
- Reply by Authors. (2020) (0)
- 452 Updated postoperative nomogram incorporating the number of positive lymph nodes to predict disease recurrence following radical prostatectomy (2015) (0)
- 263: Characteristics, Predictors of Recurrence and Survival of Patients with Seminal Vesicle Invasion after Radical Prostatectomy (2005) (0)
- Erratum to: Manifesto: towards a clinically-oriented psychometrics (2017) (0)
- A reply from Andrew Vickers (1996) (0)
- Review data related to Chapter 3 (2017) (0)
- Response from the author (2014) (0)
- Acupuncture for migraine and headache in primary care: getting a large scale, pragmatic trial off the ground (2010) (0)
- PD39-05 IMPACT OF MRI-TARGETING ON PATHOLOGIC UPGRADING AND DOWNGRADING AT PROSTATECTOMY: A SYSTEMATIC REVIEW AND META-ANALYSIS (2023) (0)
- Health Options: Complementary Therapies for Cerebral Palsy and Related Conditions (1994) (0)
- The impact of surgical experience on the risk of surgical margins and biochemical recurrence after robot-assisted radical prostatectomy: A learning-curve study (2019) (0)
- PD44-04 AGE ASSOCIATED CHANGES TO HEALTH RELATED QUALITY OF LIFE AFTER RADICAL CYSTECTOMY: A PROSPECTIVE STUDY (2023) (0)
- 1804 Development of Accurate Models for Individualized Prediction of Survival at 6 and 12 Months After Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma (2012) (0)
- EVIDENCE OF GRADE PROGRESSION FROM LONG‐TERM FOLLOW‐UP OF COHORTS NOT SUBJECT TO PROSTATE‐SPECIFIC ANTIGEN SCREENING: MP38‐08 (2017) (0)
- MP27-13 AGREEMENT BETWEEN PATIENT AND PHYSICIAN REPORTED OUTCOMES AFTER RADICAL PROSTATECTOMY (2015) (0)
- 1004 EFFECTS OF SURGEON VARIABILITY ON ONCOLOGICAL AND FUNCTIONAL OUTCOMES IN A POPULATION-BASED SETTING (2013) (0)
- MP40-11 USE OF PSA AND 4-KALLIKREIN PANEL TO IDENTIFY LETHAL PROSTATE CANCERS AND REDUCE UNNECESSARY SCREENING AND BIOPSY (2018) (0)
- Incidence-based analysis of lethal prostate cancer in Swedish counties with high versus low incidence of prostate cancer in nationwide, population-based registries. (2012) (0)
- Coxibs: recent controversies (2005) (0)
- The impact of previous depression on the risk of suicide in prostate cancer patients (2020) (0)
- MP12-07 PROSPECTIVE HEALTH RELATED QUALITY OF LIFE IN WOMEN UNDERGOING RADICAL CYSTECTOMY AND URINARY DIVERSION (2023) (0)
- 296: Correlation of Postoperative Hemoglobin Levels and Blood Loss after Laparoscopic Radical Prostatectomy (2007) (0)
- MP15-03 A SURGEON FEEDBACK SYSTEM (AMPLIO) ASSESSING FUNCTIONAL AND ONCOLOGICAL OUTCOMES FOR RADICAL PROSTATECTOMY (2021) (0)
- PD48-02 DECISION-ANALYTIC MODELING STUDY OF THE PRECISION TRIAL: DOES PRE-BIOPSY MRI DO MORE GOOD THAN HARM? (2020) (0)
- Supplement 1 zu Band 10, April 2003 (2003) (0)
- 049 Are we Improving Erectile Function Recovery after Radical Prostatectomy? Analysis of Patients Treated over the Last Decade (2019) (0)
- Implementation of 4Kscore as a Secondary Test Before Prostate Biopsy: Impact on US Population Trends for Prostate Cancer (2023) (0)
- Reply by Authors. (2022) (0)
- Corrigendum to "Young Age on Starting Prostate-specific Antigen Testing Is Associated with a Greater Reduction in Prostate Cancer Mortality: 24-Year Follow-up of the Göteborg Randomized Population-based Prostate Cancer Screening Trial" [Eur Urol (2022)]. (2022) (0)
- The effect of the da Vinci® Vessel Sealer on robot-assisted laparoscopic prostatectomy complications. (2023) (0)
- Development of 3-item questionnaire for preoperative evaluation of older cancer patients. (2017) (0)
- Assessing the net benefit of machine learning models in the presence of resource constraints (2023) (0)
- Impact on the Healthcare System (2003) (0)
- 1029 Evaluation of free psa sub forms and human glandular kallikrein 2 levels as predictors of biochemical recurrence after radical prostatectomy for localized prostate cancer (2005) (0)
- MP67-09 RACIAL DISPARITIES IN CONTINENCE AFTER RADICAL PROSTATECTOMY (2020) (0)
- MP18-16 INDIVIDUAL DATA META-ANALYSIS OF DISCRIMINATION OF THE STATISTICAL MODEL BASED ON THE FOUR KALLIKREIN PANEL ASSOCIATED WITH THE INCLUSION OF PROSTATE VOLUME (2019) (0)
- Massage and aromatherapy: an overview of practice (1996) (0)
- MP38-05 OUTCOMES OF GRADE GROUP 2 AND 3 PROSTATE CANCER ON INITIAL VERSUS CONFIRMATORY BIOPSY: IMPLICATIONS FOR ACTIVE SURVEILLANCE (2022) (0)
- MP69-06 PROSTATE-SPECIFIC ANTIGEN (PSA) LEVELS IN MEN <60 YEARS OF AGE PREDICTS LETHAL PROSTATE CANCER (2014) (0)
- How complementary healthcare can help people with disabilities (1993) (0)
- Additional file 2: of An empirical study of race times in recreational endurance runners (2016) (0)
- Re: Estimating the Benefits of PSA Screening (2010) (0)
- PRE-DIAGNOSTIC PROSTATE SPECIFIC ANTIGEN DYNAMICS DO NOT IMPROVE AN OUTCOME PREDICTION MODEL CONTAINING PROSTATE SPECIFIC ANTIGEN LEVELS ALONE IN PATIENTS WITH CLINICALLY LOCALIZED PROSTATE CANCER TREATED CONSERVATIVELY OR WITH EARLY HORMONAL THERAPY (2008) (0)
- CONCORDANCE BETWEEN PHYSICIAN‐DOCUMENTED VERSUS PATIENT‐REPORTED COMORBIDITIES IN PROSTATE CANCER: VALIDATION OF A NOVEL INFORMATICS TOOL: PD28‐08 (2017) (0)
- Editor's Note: Activator Protein-1 Transcription Factors Are Associated with Progression and Recurrence of Prostate Cancer. (2023) (0)
- Book reviewxxiii+376pp. £12.99(paper) The alternative health and medicine encyclopedia, James E. Marti, [available in UK through Routledge] , Gale Research, London (1995), ISBN: 08103 8303 9 (1996) (0)
- Standardized prostate cancer incidence and mortality rates following initial non-malignant biopsy result. (2023) (0)
- Value of PSA measured in middle age in predicting diagnosis of advanced prostate cancer in an unscreened population (2007) (0)
- 5 ASSOCIATION BETWEEN RENAL FUNCTION AND CANCER INCIDENCE IN A LARGE, POPULATION-BASED COHORT (2010) (0)
- Systemic Immunological Determinants of Oncological Outcomes After Surgery for Localized Renal Cell Carcinoma. (2022) (0)
- Abstract B28: Baseline prostate-specific antigen (PSA) levels in midlife predict aggressive prostate cancer in African-American men (2017) (0)
- Long-term oncologic outcomes of neoadjuvant chemohormonal therapy followed by radical prostatectomy for patients with clinically localized, high-risk prostate cancer. (2014) (0)
- A change of editor (1997) (0)
- Editorial comment. (2011) (0)
- Comparison of 4K score, prostate health index, and PSA density in active surveillance (2022) (0)
- LETTERS TO THE EDITORS (2000) (0)
- PD10-04 CHARACTERIZING MALE ERECTILE FUNCTION AFTER RADICAL CYSTECTOMY (2022) (0)
- 013 The Development and Implementation of a Gynecologic Cancer Survivorship Tool (2020) (0)
- 050 Improved Recovery of Erectile Function in Younger Men after Radical Prostatectomy: Does it Justify Immediate Intervention in Low-Risk Patients? (2016) (0)
- Book review: Offit P. Do You Believe in Magic? HarperCollins, New York, 2013 (2014) (0)
- Patient-reported financial toxicity following management of localized prostate cancer. (2021) (0)
- How do you tell if a change in surgical technique leads to a change in outcome? (2010) (0)
- 1874 A WEB-BASED SYSTEM FOR ASSESSING ERECTILE AND URINARY FUNCTION IN PATIENTS AFTER RADICAL PROSTATECTOMY (2010) (0)
- 652 UNIFORM ANATOMIC TEMPLATE FOR PELVIC LYMPH NODE DISSECTION DURING RADICAL PROSTATECTOMY: COMPARISON OF OPEN, LAPAROSCOPIC AND ROBOT-ASSISTED PROCEDURES (2011) (0)
- 1602: Time from Prostate Biopsy to Radical Prostatectomy does Not Impact Surgical Difficulty or Efficacy (2006) (0)
- 1149: Impact of a Multidisciplinary Continuous Quality Improvement Program on the Positive Surgical Margin Rate after Laparoscopic Radical Prostatectomy (2006) (0)
- Predicting Grade group 2 or higher cancer at prostate biopsy by 4Kscore in blood and uCaP microRNA model in urine (2022) (0)
- 985 Value of partial nephrectomy across the tumour size spectrum: A risk-benefit analysis of renal function preservation versus increased morbidity (2016) (0)
- 956: Evaluation of Human Glandular Kallikrein 2 and Free Prostate-Specific Antigen Levels as Predictors of Biochemical Recurrence after Radical Prostatectomy for Localized Prostate Cancer (2005) (0)
- 1629 PREOPERATIVE TOTAL TESTOSTERONE LEVELS DO NOT PREDICT PATHOLOGIC STAGE IN CLINICALLY LOCALIZED PROSTATE CANCER (2011) (0)
- The optimal dissemination of scientific manuscripts via social media: A prospective randomized trial comparing visual abstracts with key figures using consecutive original manuscripts published in European Urology (2022) (0)
- For pluralism in medicine (1998) (0)
- MP39-17 POOR PERFORMANCE OF THE ZAYTOUN PROSTATE BIOPSY NOMOGRAM IN MULTIPLE EXTERNAL VALIDATION COHORTS (2016) (0)
- 126 Prognostic model for predicting survival in patients with disease recurrence following radical cystectomy (2014) (0)
- 1725 PSA AT AGE 44-50 PREDICTS LONG-TERM RISK OF PROSTATE CANCER METASTASES IN AN UNSCREENED POPULATION (2010) (0)
- Independent validation of a pre-specified four-kallikrein marker model for prediction of adverse pathology and biochemical recurrence (2021) (0)
- Complementary and Alternative Medicine Approaches in Colorectal Cancer (2002) (0)
- 1876: A Single PSA Measurement in Middle Age Predicts Diagnosis of Advanced Prostate Cancer Up to 25 Years Later in an Unscreened Population (2007) (0)
- 570 PELVIC LYMPH NODE DISSECTION FOR PROSTATE CANCER IN PATIENTS WITH AN ELEVATED RISK OF LYMPH NODE INVASION IN A CONCURRENT CONTEMPORARY SERIES: COMPARISON OF OPEN, LAPAROSCOPIC AND ROBOT-ASSISTED APPROACHES. (2011) (0)
- MP09-17 PREDICTING INCIDENCE VERSUS MORTALITY FOR CANCERS ASSOCIATED WITH OVERDIAGNOSIS: AN OVERLOOKED ISSUE FOR POLYGENIC RISK SCORES AND CANCER SCREENING (2022) (0)
- Complementary medicine: a research perspective, Charles Vincent, Adrian Furnham. Chicester; Wiley (1997), 305pp Price £22.50 (pbk) (1998) (0)
- 859 Evaluating the impact of adulthood metabolic disorders on prostatic cancer etiology with early-in-life risk factors (2014) (0)
- CAM Research Issues (2003) (0)
- Organizing massage and aromatherapy in conventional health settings (1996) (0)
- 407: Time Course of Upper Tract Recurrence Following Radical Cystectomy for Urothelial Cancer (2007) (0)
- 1159 PREDICTING THE RISK OF BLADDER CANCER AND HIGH-GRADE BLADDER CANCER USING PATIENT CLINICAL AND DEMOGRAPHIC INFORMATION FROM PLCO PARTICIPANTS (2010) (0)
- Impact of Zone of Origin in Anterior Dominant Prostate Cancer: Long-Term Biochemical Recurrence-Free Survival in an Anatomically Well-Characterized Cohort. (2022) (0)
- 911 PREDICTION OF OUTCOME AFTER RADICAL PROSTATECTOMY USING A TISSUE MICROARRAY OF 947 PRIMARY PROSTATE CANCERS AND IMMUNOHISTOCHEMICAL DETECTION OF CYSTEINE-RICH SECRETORY PROTEIN 3 (CRISP-3) AND BETA-MICROSEMINOPROTEIN (MSP) (2007) (0)
- 508 A COMPARISON OF BIOCHEMICAL RECURRENCE RATES OF OPEN AND ROBOTIC PROSTATECTOMY AT A LARGE TERTIARY CARE CENTER (2012) (0)
- CAM Use and Users (2003) (0)
- Electronic symptom monitoring with patient-reported outcomes in patients recovering from ambulatory minimally invasive gynecologic cancer surgery: A prospective pilot study (2019) (0)
- Theoretical Net Benefit of a Radiomics-based Computer Aided Diagnosis Tool for Risk Stratification of Pulmonary Nodules (2023) (0)
- The development and implementation of a gynecologic cancer survivorship tool. (2019) (0)
- Preoperative frailty vs. cognitive impairment: Which one matters most for postoperative delirium among older adults with cancer? (2023) (0)
- 1233 WHOM SHOULD WE SCREEN FOR BLADDER CANCER? A DECISION ANALYSIS OF DATA FROM THE PLCO (2011) (0)
- Author Reply. (2016) (0)
- 639 EVALUATION OF CANCER CONTROL AFTER OPEN AND LAPAROSCOPIC RADICAL PROSTATECTOMY (2009) (0)
- The knowledge and practices of urologists in the United States (US) about standardization of PSA assays. (2011) (0)
- International multi-centre study of incidence and risk factors of symptomatic deep venous thrombosis (DVT) and or pulmonary embolism (PE) in prostate cancer patients undergoing laparoscopic radical prostatectomy (LRP). (2006) (0)
- PD47-04 SURGICAL AND ONCOLOGIC OUTCOMES IN PATIENTS UNDERGOING RADICAL CYSTECTOMY FROM 1995-2015: THE MEMORIAL SLOAN KETTERING EXPERIENCE (2019) (0)
- 1217 THE PROSTATE CANCER PREVENTION TRIAL (PCPT) RISK CALCULATOR AND THE RELATIONSHIP BETWEEN PSA AND BIOPSY OUTCOME (2012) (0)
- Reply: To PMID 25623680. (2015) (0)
- Methods Modernizing Statistical Reporting in Medical Journals: Challenges and Future Directions. (2022) (0)
- Gynecologic Survivorship Tool: Development, Implementation, and Symptom Outcomes (2022) (0)
- approaches to nutritional medicine ABC of complementary medicine: Unconventional (2007) (0)
- 1782 THE ROLE OF IMMEDIATE RADICAL CYSTECTOMY IN THE TREATMENT OF PATIENTS WITH RESIDUAL T1 ON RESTAGING TRANSURETHRAL RESECTION (2012) (0)
- Author's response: Probabilistic predictions, medical decisions, and clinical usefulness (2010) (0)
- Does a brief surgeon training in negotiation theory principles decrease rates of contralateral prophylactic mastectomy? (2023) (0)
- Reply to D.A. Hamstra et al and A.P. Sandhu (2010) (0)
- A surgeon feedback system (AMPLIO) for nerve-sparing radical prostatectomy assessing functional and oncological outcomes (2020) (0)
- Race, Biology, Disparities, and Prostate Cancer. (2022) (0)
- Guidelines for reporting observational research in urology: the importance of clear reference to causality. (2023) (0)
- Response to Comments on: Does use of alternative medicine predict survival from cancer? Eur J Cancer 2003, 39, 372–377 (2003) (0)
- PD55-05 NEGATIVE MRI CANNOT BE USED TO AVOID BIOPSY IN ACTIVE SURVEILLANCE FOR PROSTATE CANCER (2019) (0)
- Clinical Consultation Guide: How to Optimize the Use of Prostate-specific Antigen in the Current Era. (2015) (0)
- Development of memorial Sloan Kettering (MSK) surgery stress score for older adults with cancer. (2022) (0)
- Acupuncture characteristics related to trials in Chapter 2 (2017) (0)
- Interview with the Principal Researcher (2004) (0)
- PSA velocity does not aid the detection of prostate cancer in men with a prior negative biopsy: data from the European Randomized Study of Prostate Cancer Screening in Göteborg, Sweden and Rotterdam, Netherlands (2012) (0)
- A pre-specified model based on four kallikrein markers in blood improves predictions of adverse pathology and biochemical recurrence after radical prostatectomy (2020) (0)
- 1750: PSA Velocity does not aid long-term Prediction of Cancer in a large Representative Population of middle-aged men with no History of Prior PSA-Testing (2007) (0)
- What is a good medical choice? (2021) (0)
- In reply. (2013) (0)
- What happens in complementary healthcare (1993) (0)
- Special health care settings (1996) (0)
- Health-related Quality of Life After Robotic-assisted vs Open Radical Cystectomy: Analysis of a Randomized Trial (2023) (0)
- Rapid elimination kinetics of free PSA and hK2 following initiation of GnRH-antagonist treatment of aggressive Prostate Cancer (2008) (0)
- Contents Vol. 17, 2010 (2010) (0)
- The NHS and complementary therapies (1994) (0)
- Screening for prostate cancer: To the editor (2012) (0)
- Can healthy homoeopaths distinguish Bryonia in a 12c potency from placebo by taking both preparations and observing their effects? A pilot study (2010) (0)
- PD41-09 MOVING BEYOND PSA: IDENTIFYING THE OPTIMAL DIAGNOSTIC STRATEGY TO ASSESS PROSTATE CANCER RISK (2022) (0)
- MP69-11 INFLUENCE OF BLOOD LEVELS OF PROSTATE-SPECIFIC ANTIGEN AT AGE 60 ON THE BENEFITS AND HARMS OF PROSTATE CANCER SCREENING (2014) (0)
- Uretero‐enteric stricture outcomes: secondary analysis of a randomised controlled trial comparing open versus robot‐assisted radical cystectomy (2022) (0)
- 2135 A PREDICTION BASED ON LEVELS OF FOUR KALLIKREIN MARKERS IN BLOOD IMPROVES PREOPERATIVE PREDICTION OF INDOLENT VERSUS AGGRESSIVE PROSTATE CANCER IN RADICAL PROSTATECTOMY SPECIMENS (2013) (0)
- Pre-cancer cardiovascular risk factors and anthracycline-related cardiotoxicity among non-Hodgkin lymphoma survivors. (2016) (0)
- PD53-11 PRIMARY CARE PHYSICIANSʼ PERCEPTIONS OF AN ELECTRONIC MEDICAL RECORD-EMBEDDED DECISION SUPPORT TOOL FOR PROSTATE CANCER SCREENING (2020) (0)
- Problems with Numbers in Decision Aids for Prostate-specific Antigen Screening: A Critical Review. (2020) (0)
- Prospective validation of microseminoprotein‐β added to the 4Kscore in predicting high‐grade prostate cancer in an international multicentre cohort (2020) (0)
- Ureteroenteric Stricture Outcomes: Secondary analysis of an RCT comparing open vs robotic cystectomy. (2022) (0)
- WHAT IS THE SENSITIVITY AND SPECIFICITY OF THE PROSTATE SPECIFIC ANTIGEN (PSA) TEST FOR PROSTATE CANCER? SCREENING STUDIES ARE SUBJECT TO VERIFICATION BIAS AND STATISTICAL CORRECTIONS ARE INADEQUATE IN THIS SETTING (2008) (0)
- Guidelines for Reporting of Figures and Tables for Clinical Research in Urology (2020) (0)
- DMAC Fatigued Shackle (2013) (0)
- Introduction to massage and aromatherapy (1996) (0)
- PD09-04 ESTIMATING THE HARMS AND BENEFITS OF PROSTATE CANCER SCREENING: COMPARING COMMON CLINICAL PRACTICE TO RECOMMENDED GOOD PRACTICE (2016) (0)
- Individualised non-contrast MRI-based risk estimation and shared decision-making in men with a suspicion of prostate cancer: protocol for multicentre randomised controlled trial (multi-IMPROD V.2.0) (2022) (0)
- From clinical trials to clinical practice: how should we design and evaluate prediction models in the care of IBD? (2021) (0)
- Subject Index Vol. 6, 1999 (1999) (0)
- PC‐SPES Story Not Over Yet (2002) (0)
- 527: Screening for Prostate Cancer: Effects of Age and Time to Diagnosis on the Prognostic Value of Total PSA, Free PSA and HK2 (2006) (0)
- Research, Uncertainty, and Alternative Medicine (1996) (0)
- Selecting Patients with Favourable-Risk, GG2 Prostate Cancer for Active Surveillance: Does MRI Have a Role? (2020) (0)
- Health Services Research : Quality Improvement & Patient Safety II Moderated Poster 72 (2023) (0)
- Value of Information Analysis for External Validation of Risk Prediction Models (2022) (0)
- [Does use of alternative medicine aggravate the survival prognosis in cancer?]. (2003) (0)
- Automated patient-reported symptom data capture, tracking, and intervention during recovery from ambulatory gynecologic cancer surgery: A prospective study (2017) (0)
- Comment on: Does use of alternative medicine predict survival from cancer? Authors' reply (2003) (0)
- Prostate-specific antigen velocity in a prospective prostate cancer screening study of men with genetic predisposition (vol 118, pg 266, 2018) (2018) (0)
- Suggestions for modifications to the Female Sexual Function Index based on cognitive interviews with sexual and gender minority individuals and cisgender, heterosexual persons. (2023) (0)
- webGURU : Guide for Undergraduate Research (2015) (0)
- Significance of Non-Calcified Pulmonary Nodules (2017) (0)
- Subject Index Vol. 17, 2010 (2010) (0)
This paper list is powered by the following services:
Other Resources About Andrew Vickers
What Schools Are Affiliated With Andrew Vickers?
Andrew Vickers is affiliated with the following schools:
- University of Western Ontario
- University of California, Berkeley
- Boston University
- Aalborg University
- University of Oxford
- KU Leuven
- University of Michigan
- Wayne State University
- University of California, San Francisco
- University of Turin
- Fordham University
- University of Turku
- Albert Einstein College of Medicine
- Stanford University
- Lund University
